{"meta":{"query_hash":"a80a3a1c26f4","filters":{"venue":"ClinicoEconomics and Outcomes Research"},"cohort_total":83,"direct_labels_cover":2,"predictions_cover":83,"exported":83,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a80a3a1c26f4","api":"https://metacan.xera.ac/api/v1/cohort?venue=ClinicoEconomics+and+Outcomes+Research"},"results":[{"id":"W1432569973","doi":"10.2147/ceor.s87462","title":"Acceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness threshold","year":2015,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Excellence","keywords":"Medicine; Cost effectiveness; Health technology; Data science; Computer science; Risk analysis (engineering); Health care; Economics","score_opus":0.6512456712451083,"score_gpt":0.6109980830969306,"score_spread":0.04024758814817775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1432569973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9477226,0.0022883965,0.0031516007,0.037148826,0.0005518643,0.006453253,0.00030933126,0.00004568629,0.0023284543],"genre_scores_gemma":[0.99540186,0.00051083334,0.00082402263,0.0016921648,0.00008686797,0.0012442106,0.000036800022,0.000052470637,0.00015078267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99284935,0.0018230082,0.0034008655,0.0009020167,0.00022590121,0.00079886924],"domain_scores_gemma":[0.99038625,0.006053454,0.0018038044,0.0010398544,0.00033526984,0.0003813533],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.07039866,0.00029916863,0.0017915196,0.0006171705,0.00058025564,0.00016298096,0.0007181691,0.00023793173,0.00009069289],"category_scores_gemma":[0.0027069435,0.00025508416,0.00013093672,0.00046262585,0.0007532261,0.00044736944,0.00037609486,0.00078111776,0.0001372178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010889702,0.00020571187,0.81007665,0.00024930685,0.00015777937,9.692724e-7,0.0004913868,0.0003073244,0.0000029780026,0.1846708,0.0009403069,0.0027878506],"study_design_scores_gemma":[0.005742377,0.0010389101,0.9226982,0.00024208936,0.000011896948,0.000012145129,0.010633353,0.00469916,0.00006383238,0.03575516,0.018590208,0.00051267387],"about_ca_topic_score_codex":0.0007127244,"about_ca_topic_score_gemma":0.00041726168,"teacher_disagreement_score":0.14891565,"about_ca_system_score_codex":0.001568203,"about_ca_system_score_gemma":0.0014158142,"threshold_uncertainty_score":0.99999017},"labels":[],"label_agreement":null},{"id":"W1657561747","doi":"10.2147/ceor.s39624","title":"Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions","year":2013,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eli Lilly and Company","keywords":"Nice; Medicine; Reimbursement; Listing (finance); Excellence; Health technology; Formulary; Family medicine; Clinical trial; Evidence-based medicine; Alternative medicine; Actuarial science; Health care; Business; Political science; Pathology","score_opus":0.7391213635127992,"score_gpt":0.6622200595753441,"score_spread":0.07690130393745509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1657561747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86243385,0.0013240073,0.0009962104,0.13184398,0.000860682,0.0020805781,0.00023484629,0.000055976536,0.0001698704],"genre_scores_gemma":[0.9813488,0.0041826516,0.00654896,0.0062724613,0.0002632355,0.0008937831,0.000018328312,0.00006569218,0.00040607687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98793787,0.0011302746,0.007715933,0.0016744203,0.00017286268,0.0013686466],"domain_scores_gemma":[0.9852547,0.010572008,0.0012532312,0.0017168444,0.00021408098,0.0009891526],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.038826406,0.00038193516,0.002236655,0.0010927306,0.00091639714,0.00068844185,0.0007800164,0.00031109407,0.00034491194],"category_scores_gemma":[0.010523283,0.000393943,0.00023053335,0.00044995802,0.00056604965,0.0013904702,0.0008233285,0.0012149573,0.0014272779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029850678,0.00037149276,0.9415844,0.000071422495,0.000051077463,0.000023695764,0.0007876692,0.000044798362,5.6877354e-7,0.033921897,0.002099822,0.021013277],"study_design_scores_gemma":[0.0012404432,0.0011999231,0.9346472,0.00022388737,0.0000036402669,0.0001313864,0.010986478,0.0045880773,0.0000010934413,0.03871588,0.0077430317,0.000518953],"about_ca_topic_score_codex":0.0040153824,"about_ca_topic_score_gemma":0.033561893,"teacher_disagreement_score":0.12557152,"about_ca_system_score_codex":0.0010382526,"about_ca_system_score_gemma":0.0005457749,"threshold_uncertainty_score":0.9998512},"labels":[],"label_agreement":null},{"id":"W1827447754","doi":"10.2147/ceor.s90386","title":"Bias within economic evaluations – the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug","year":2015,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Programs for Assessment of Technology in Health Research Institute; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Time horizon; Economic model; Cost–benefit analysis; Generic drug; Medicine; Cost effectiveness; Econometrics; Operations research; Actuarial science; Computer science; Economics; Mathematics; Mathematical optimization; Drug; Risk analysis (engineering); Pharmacology; Microeconomics","score_opus":0.7251800489594876,"score_gpt":0.6174641511457643,"score_spread":0.10771589781372337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1827447754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876942,0.001453691,0.00017235891,0.005904574,0.0009990602,0.0025293857,0.0007579607,0.000011577248,0.00047716728],"genre_scores_gemma":[0.99790657,0.0005739131,0.00044192647,0.00039987633,0.0002689919,0.00014218244,0.00006385792,0.000042038228,0.00016065681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932171,0.0013228606,0.0042432356,0.00056157564,0.00019602382,0.00045921325],"domain_scores_gemma":[0.9875002,0.008046104,0.0028583156,0.0010165214,0.00027593857,0.00030290088],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04029047,0.0002877824,0.0014262822,0.0004401601,0.0002566414,0.00011530511,0.00064684084,0.00016558441,0.00018221556],"category_scores_gemma":[0.0052456013,0.00022560653,0.00034393722,0.00022926145,0.00047282485,0.0003026209,0.0002653256,0.0005164583,0.00018113496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056240417,0.0004197762,0.86671704,0.00032913432,0.0007631437,6.576617e-7,0.0077525508,0.05223173,0.000019721008,0.042585142,0.025593732,0.0030249932],"study_design_scores_gemma":[0.013774471,0.001751412,0.7451014,0.00057560316,0.00011556709,0.000025776766,0.016163016,0.15420142,0.0005771933,0.051391464,0.015060493,0.0012622046],"about_ca_topic_score_codex":0.00276341,"about_ca_topic_score_gemma":0.0011219087,"teacher_disagreement_score":0.12161563,"about_ca_system_score_codex":0.00095748296,"about_ca_system_score_gemma":0.001880769,"threshold_uncertainty_score":0.9882229},"labels":[],"label_agreement":null},{"id":"W1888218106","doi":"10.2147/ceor.s82549","title":"Evolution of health technology assessment: best practices of the pan-Canadian Oncology Drug Review","year":2015,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ciena (Canada)","funders":"","keywords":"Best practice; Stakeholder; Agency (philosophy); Medicine; Stakeholder engagement; Health care; Health technology; Public relations; Relevance (law); Medical education; Political science; Sociology","score_opus":0.7382198920775018,"score_gpt":0.6538015955181725,"score_spread":0.08441829655932931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1888218106","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3844509,0.08071407,0.000057833564,0.5153666,0.0010842141,0.0021875368,0.00031468456,0.000014964536,0.015809193],"genre_scores_gemma":[0.96980006,0.020746414,0.0014887416,0.0064514247,0.00009801535,0.000108825145,0.000012971449,0.000030424102,0.001263151],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924975,0.0013898155,0.0049366653,0.0005059036,0.00012454818,0.00054555177],"domain_scores_gemma":[0.9898629,0.002644504,0.0059568165,0.0008913946,0.000327345,0.00031702794],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.07228518,0.00014776924,0.0016283046,0.0007408864,0.00024391137,0.00003070597,0.00067651976,0.00021201123,0.0000885691],"category_scores_gemma":[0.014644806,0.00014302215,0.00014308958,0.0004217735,0.0005177707,0.00028816256,0.00025537255,0.00057999685,0.00022982893],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005867043,0.00013943983,0.72861755,0.0010630569,0.00007319931,2.3977958e-7,0.00043841352,0.000011305044,2.5189732e-7,0.247097,0.016843472,0.005710221],"study_design_scores_gemma":[0.0018643043,0.0006236252,0.21143329,0.0009340784,0.000021464368,0.000010989375,0.014340831,0.0015453063,0.0000028507477,0.079594806,0.68926156,0.00036687948],"about_ca_topic_score_codex":0.06822622,"about_ca_topic_score_gemma":0.03727115,"teacher_disagreement_score":0.6724181,"about_ca_system_score_codex":0.0021411595,"about_ca_system_score_gemma":0.0053805606,"threshold_uncertainty_score":0.99365526},"labels":[],"label_agreement":null},{"id":"W1893993642","doi":"10.2147/ceor.s82194","title":"Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective","year":2015,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"Celgene","keywords":"Paclitaxel; Docetaxel; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Perspective (graphical); Cancer; Internal medicine","score_opus":0.18292777179286226,"score_gpt":0.5555170525744136,"score_spread":0.3725892807815514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1893993642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651208,0.007974206,0.000017321683,0.02244996,0.00023642916,0.0015471678,0.002214838,0.000028755461,0.00041052888],"genre_scores_gemma":[0.9945793,0.0016607426,0.00038516524,0.0020983482,0.00015835706,0.00034401432,0.00026869256,0.000033095755,0.00047224917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966582,0.0005740081,0.000825814,0.0008792226,0.00031393245,0.000748814],"domain_scores_gemma":[0.99640757,0.0014889137,0.00020496975,0.00055924087,0.0005038563,0.00083544914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001895524,0.00032366937,0.001582155,0.00075556093,0.00015813917,0.00008534306,0.0002017975,0.00012493324,0.0008725246],"category_scores_gemma":[0.00037334507,0.0002358755,0.00035547742,0.0008676583,0.0003527978,0.00012849021,0.00014591041,0.00070539437,0.000030193516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004398564,0.00082381157,0.97655135,0.000098875935,0.0016312025,0.00007242735,0.0045282207,0.00006593824,0.0000024979674,0.000047704103,0.0012703898,0.010508998],"study_design_scores_gemma":[0.017122304,0.0011342769,0.9557332,0.00004615427,0.0006308527,0.000006571525,0.015195828,0.006709661,0.0000062124554,0.00058091636,0.0025588297,0.00027519464],"about_ca_topic_score_codex":0.041687932,"about_ca_topic_score_gemma":0.07391738,"teacher_disagreement_score":0.03222945,"about_ca_system_score_codex":0.0022329842,"about_ca_system_score_gemma":0.0034444802,"threshold_uncertainty_score":0.96469355},"labels":[],"label_agreement":null},{"id":"W1910786395","doi":"10.2147/ceor.s42649","title":"Follow-up analysis of federal process of care data reported from three acute care hospitals in rural Appalachia","year":2013,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pacific Centre for Reproductive Medicine","funders":"","keywords":"Medicaid; Medicine; Medical record; Acute care; Family medicine; Demography; Health care; Emergency medicine; Internal medicine","score_opus":0.1400537942355443,"score_gpt":0.5347350271289409,"score_spread":0.3946812328933966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1910786395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911678,0.0014597721,0.000005691797,0.0018423033,0.00046733333,0.0015136218,0.0013218424,0.000019133126,0.0022024964],"genre_scores_gemma":[0.9957084,0.001036552,0.00026741554,0.0007047307,0.00007513104,0.00014524363,0.0017364156,0.00003357017,0.00029251067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99547905,0.00040160885,0.0022958105,0.0006836958,0.00035334798,0.0007864842],"domain_scores_gemma":[0.99378544,0.0025659117,0.0007313858,0.0016967567,0.0009663445,0.00025415327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016635982,0.00023731527,0.0017423393,0.00074865134,0.0003561325,0.000039291815,0.0009897937,0.00038904164,0.0005589413],"category_scores_gemma":[0.000698792,0.00020087382,0.00024295661,0.00058016845,0.00022113358,0.00041904885,0.0011514853,0.0010232279,0.000035827772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013136728,0.000029738847,0.9796938,0.0004886897,0.00089927326,0.000003728438,0.0060396716,0.0000038323024,0.00000746477,0.00007501983,0.0011244158,0.011503054],"study_design_scores_gemma":[0.0019935172,0.00012990333,0.9655648,0.00007259744,0.00025928504,1.07562606e-7,0.030014317,0.0006858495,0.000007654794,0.0007817826,0.00031027794,0.00017993388],"about_ca_topic_score_codex":0.0173347,"about_ca_topic_score_gemma":0.046348765,"teacher_disagreement_score":0.029014066,"about_ca_system_score_codex":0.00031134803,"about_ca_system_score_gemma":0.0018508614,"threshold_uncertainty_score":0.98920894},"labels":[],"label_agreement":null},{"id":"W1973529506","doi":"10.2147/ceor.s33444","title":"Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"Ontario Ministry of Health and Long-Term Care; AstraZeneca Canada; AstraZeneca","keywords":"Live attenuated influenza vaccine; Medicine; Vaccination; Pediatrics; Influenza vaccine; Immunology","score_opus":0.17969868565364,"score_gpt":0.486553965957672,"score_spread":0.306855280304032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973529506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507236,0.0013427042,0.000011357756,0.0003709572,0.00013007985,0.0025722713,0.0003791534,0.000017819948,0.000103281905],"genre_scores_gemma":[0.99792844,0.0012037301,0.00009812877,0.00027890687,0.00010439301,0.00016168656,0.00013097745,0.000045264464,0.00004845912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970338,0.00028816145,0.0007064085,0.00052733696,0.00026029575,0.0011840091],"domain_scores_gemma":[0.9953377,0.0024240748,0.00015397504,0.0004641095,0.00077821186,0.000841893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033730732,0.00029367098,0.0013390251,0.0016488226,0.00036041724,0.000057870973,0.00019560469,0.00024149567,0.0000706715],"category_scores_gemma":[0.0023618273,0.00025404777,0.0002100838,0.00082542177,0.00019954004,0.00025828643,0.0002839727,0.00064386165,0.000013113298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057477625,0.00019707867,0.97898924,0.00018894562,0.004331534,0.0000018484105,0.00041976006,0.000026306976,0.00012093102,0.000107849264,0.00020648868,0.009662236],"study_design_scores_gemma":[0.01215502,0.0006974102,0.98324543,0.00008276859,0.0006693201,0.0000020195555,0.0003927305,0.0009443764,0.00045361274,0.000018019746,0.0011198706,0.00021944827],"about_ca_topic_score_codex":0.036362287,"about_ca_topic_score_gemma":0.022554005,"teacher_disagreement_score":0.013808284,"about_ca_system_score_codex":0.0005591446,"about_ca_system_score_gemma":0.0004046173,"threshold_uncertainty_score":0.9999912},"labels":[],"label_agreement":null},{"id":"W1997613802","doi":"10.2147/ceor.s30547","title":"Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada","funders":"Public Health Agency; Public Health Agency of Canada","keywords":"Prediabetes; Medicine; Impaired fasting glucose; Type 2 diabetes; Type 2 Diabetes Mellitus; Diabetes mellitus; Impaired glucose tolerance; Asymptomatic; Internal medicine; Endocrinology","score_opus":0.06121437795526665,"score_gpt":0.3701620616856872,"score_spread":0.3089476837304206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997613802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966514,0.002889688,0.000044859375,0.000023071352,0.0000349572,0.0003093497,0.000009793127,0.0000032877367,0.000033555345],"genre_scores_gemma":[0.9991651,0.00041733688,0.00032951625,0.000011508887,0.000040398783,0.0000058034852,0.0000022552476,0.000014880682,0.00001318021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891657,0.000076015596,0.00038928207,0.00017570614,0.0001336037,0.0003088384],"domain_scores_gemma":[0.99892056,0.0005390221,0.000097415854,0.00017362509,0.00011110355,0.00015827995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015223166,0.00009786452,0.0005320586,0.00017569319,0.000044052413,0.000014373797,0.000036461184,0.00006985642,0.0000027463745],"category_scores_gemma":[0.00049024593,0.000086041444,0.0000825245,0.0001043302,0.00009179814,0.00014350856,0.00007489158,0.00020650984,1.4898768e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010003201,0.00001730949,0.6998659,0.00008172117,0.000075057265,2.8899026e-7,0.00011499722,0.0013552726,0.00024074172,0.0000012699894,6.214302e-7,0.2981468],"study_design_scores_gemma":[0.0010101803,0.00016859875,0.7833527,0.000053719694,0.000020218225,6.1296265e-7,0.00007796478,0.21493244,0.00030090217,0.00001962644,0.000004645922,0.00005844225],"about_ca_topic_score_codex":0.29161453,"about_ca_topic_score_gemma":0.08098637,"teacher_disagreement_score":0.29808837,"about_ca_system_score_codex":0.000111154535,"about_ca_system_score_gemma":0.00023751054,"threshold_uncertainty_score":0.9357832},"labels":[],"label_agreement":null},{"id":"W1998206968","doi":"10.2147/ceor.s78115","title":"Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management","year":2015,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; Oakville Public Library; University of Toronto; McMaster University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Ulipristal acetate; Medicine; Uterine fibroids; Gynecology; Internal medicine; Family planning; Population; Environmental health","score_opus":0.11901442888560035,"score_gpt":0.4712039561897308,"score_spread":0.35218952730413045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998206968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550194,0.00020815645,0.0000037820203,0.00080190925,0.0000334762,0.0006695057,0.000093423165,0.000003055013,0.0026847443],"genre_scores_gemma":[0.9989241,0.00026143843,0.00040392342,0.00015053076,0.000010569189,0.00003497113,0.000054225835,0.000008879326,0.00015141375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987305,0.00013218953,0.0005246594,0.00020862388,0.00017100722,0.00023301737],"domain_scores_gemma":[0.9989981,0.00021229335,0.0001130184,0.00036742724,0.00012069806,0.00018845446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013304431,0.00010238633,0.0005206428,0.0005580568,0.000038889273,0.000022792947,0.00015767515,0.00003943228,0.000042667914],"category_scores_gemma":[0.000041041523,0.00007107459,0.00011893628,0.0003905829,0.00013614632,0.000043999324,0.00008483354,0.00014314981,0.0000028083737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012098549,0.000101105376,0.9668819,0.000164227,0.00089308113,0.000037397178,0.0017083817,0.000027249844,0.0000096090835,0.00020959039,0.000045363347,0.02980111],"study_design_scores_gemma":[0.0034364623,0.00030288848,0.9822024,0.0000311706,0.00024091743,0.000002679887,0.0042397827,0.0074324314,0.00006286261,0.00015258281,0.0018230223,0.00007276576],"about_ca_topic_score_codex":0.014024727,"about_ca_topic_score_gemma":0.022353765,"teacher_disagreement_score":0.029728344,"about_ca_system_score_codex":0.00013794865,"about_ca_system_score_gemma":0.00017783466,"threshold_uncertainty_score":0.9954857},"labels":[],"label_agreement":null},{"id":"W2004742061","doi":"10.2147/ceor.s51052","title":"Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada","year":2014,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto; University Health Network; St. Paul's Hospital; McMaster University; Programs for Assessment of Technology in Health Research Institute; St. Joseph’s Healthcare Hamilton; AstraZeneca (Canada); University of Alberta Hospital; Alberta Hospital Edmonton","funders":"University of Toronto; Heart and Stroke Foundation of Canada","keywords":"Ticagrelor; Clopidogrel; Medicine; Acute coronary syndrome; Cardiology; Internal medicine; Aspirin; Intensive care medicine; Myocardial infarction","score_opus":0.06132080415009829,"score_gpt":0.37724270325244,"score_spread":0.31592189910234175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004742061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99864805,0.00017918386,0.000004455324,0.00007959027,0.00010793967,0.0007022313,0.000023158766,0.0000030762296,0.0002522908],"genre_scores_gemma":[0.9993172,0.00047351944,0.00003505583,0.000058558722,0.0000092919145,0.000032201027,0.000032781805,0.0000166563,0.000024679031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865675,0.00025581542,0.00030855724,0.00027159983,0.00021210052,0.0002951659],"domain_scores_gemma":[0.99807775,0.00137438,0.000044553795,0.0002854724,0.0000834623,0.00013440492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011154517,0.00011385889,0.0006105927,0.00015803723,0.000029619303,0.000008802125,0.00010045036,0.000062574065,0.000023947317],"category_scores_gemma":[0.00013050184,0.000089628185,0.00007766444,0.0001232484,0.00014680342,0.000053937154,0.0000674832,0.00026079043,0.0000037443785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052195187,0.00012428686,0.9574733,0.00009956524,0.0003218888,0.000042072665,0.000019435838,0.000029676377,6.2508855e-7,0.00013944661,0.00000850662,0.036521703],"study_design_scores_gemma":[0.014834788,0.0006555259,0.98357713,0.000099686324,0.000036380996,0.0000031906764,0.00010674931,0.00018066753,0.000015476982,0.000047797384,0.00034592082,0.000096691045],"about_ca_topic_score_codex":0.034961037,"about_ca_topic_score_gemma":0.07531723,"teacher_disagreement_score":0.04035619,"about_ca_system_score_codex":0.00027403948,"about_ca_system_score_gemma":0.0006998475,"threshold_uncertainty_score":0.97146523},"labels":[],"label_agreement":null},{"id":"W2007548426","doi":"10.2147/ceor.s63187","title":"Conversion of the Seattle Angina Questionnaire into EQ-5D utilities for ischemic heart disease: a systematic review and catalog of the literature","year":2014,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Centre hospitalier universitaire de Québec; St. Michael's Hospital","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Angina; EQ-5D; Cochrane Library; Revascularization; Quality of life (healthcare); Coronary artery disease; MEDLINE; Bypass grafting; Internal medicine; Disease; Physical therapy; Meta-analysis; Artery; Health related quality of life; Myocardial infarction","score_opus":0.42344563812516706,"score_gpt":0.531508440018112,"score_spread":0.10806280189294498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007548426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00082225696,0.982143,0.000010020559,0.009815657,0.00042789374,0.005360841,0.0013659091,0.0000076498545,0.000046792644],"genre_scores_gemma":[0.0022706797,0.9933713,0.00006699486,0.0021712198,0.00009967574,0.0005907589,0.000079277605,0.000053025837,0.001297063],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99225724,0.0013222229,0.0052215187,0.0006897442,0.0001240925,0.00038515788],"domain_scores_gemma":[0.9887876,0.0059544723,0.0033266083,0.0015060061,0.00023208096,0.00019322682],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.023225911,0.00035552811,0.0049681547,0.00028258262,0.00033003566,0.000100028665,0.00082776614,0.0003404256,0.000019747715],"category_scores_gemma":[0.012800742,0.0002464175,0.00085592526,0.00024196891,0.0006125494,0.00017536481,0.0004933713,0.00055066467,0.00003848236],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004580668,0.000027701319,0.0050063883,0.9754321,0.00016103803,4.9977572e-8,0.00031700847,2.7535887e-7,9.152897e-9,0.011633761,0.007142021,0.00027505006],"study_design_scores_gemma":[0.00066135975,0.000085621235,0.0026016817,0.4262921,0.000722482,0.000010511883,0.00030211246,0.00021394154,3.358109e-7,0.008113029,0.5604471,0.000549696],"about_ca_topic_score_codex":0.00010276171,"about_ca_topic_score_gemma":0.000023850112,"teacher_disagreement_score":0.5533051,"about_ca_system_score_codex":0.00030928955,"about_ca_system_score_gemma":0.0005755516,"threshold_uncertainty_score":0.9999988},"labels":[],"label_agreement":null},{"id":"W2010903473","doi":"10.2147/ceor.s16675","title":"Cost considerations in the management of atrial fibrillation – impact of dronedarone","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center","funders":"","keywords":"Dronedarone; Medicine; Atrial fibrillation; Management of atrial fibrillation; Cardiology; Intensive care medicine; Internal medicine; Amiodarone","score_opus":0.36286953161102875,"score_gpt":0.5422575221405838,"score_spread":0.179387990529555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010903473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938374,0.0005507599,0.000029870467,0.0018260349,0.00013377135,0.0010725183,0.00001577175,0.000005168427,0.0025286912],"genre_scores_gemma":[0.9971082,0.0010309384,0.0010166989,0.00003661019,0.0003099117,0.0000025955503,0.00002773681,0.000010346944,0.0004569193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851847,0.00015405632,0.00068634667,0.00014644014,0.00022018803,0.00027452142],"domain_scores_gemma":[0.9978403,0.0015127521,0.00016235822,0.00033198635,0.00007294289,0.00007968589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029985423,0.00010103367,0.00042162708,0.00027107823,0.0000772233,0.000025646577,0.00007118635,0.00007242292,0.00022980556],"category_scores_gemma":[0.00022510688,0.000068672125,0.00028447117,0.00017824072,0.0001634689,0.00013423925,0.000111320165,0.00015138295,0.000020733423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015920037,0.000014349959,0.9783316,0.00008209718,0.00023795,6.6192086e-7,0.000524526,0.0001656112,0.000014242605,0.011362124,0.00026962158,0.008837977],"study_design_scores_gemma":[0.002095114,0.0001232973,0.99115103,0.00002496932,0.00006912067,0.0000027399701,0.0005451199,0.00018929712,0.000010681876,0.0010209553,0.0047041564,0.00006349417],"about_ca_topic_score_codex":0.000095655676,"about_ca_topic_score_gemma":0.000028283344,"teacher_disagreement_score":0.012819416,"about_ca_system_score_codex":0.000075717384,"about_ca_system_score_gemma":0.000066561726,"threshold_uncertainty_score":0.2800368},"labels":[],"label_agreement":null},{"id":"W2014266678","doi":"10.2147/ceor.s66309","title":"Oncology drug health technology assessment recommendations: Canadian versus UK experiences","year":2014,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Alternative medicine; Drug; Family medicine; Data science; Bioinformatics; Pharmacology; Pathology; Biology; Computer science","score_opus":0.6008255346384248,"score_gpt":0.63700972465046,"score_spread":0.03618419001203521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014266678","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4477503,0.0013090086,0.00022339086,0.52531976,0.0025877242,0.0009286599,0.00013014648,0.00005354056,0.021697486],"genre_scores_gemma":[0.9706891,0.0019880377,0.006806006,0.01811497,0.0003374134,0.0005320287,0.0000674756,0.000045065422,0.0014198805],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930724,0.0009273164,0.0038781355,0.000945146,0.000092536015,0.001084491],"domain_scores_gemma":[0.99156064,0.0054997415,0.0012355988,0.0008067374,0.00012169548,0.00077556726],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.044649374,0.00022860696,0.0013713556,0.0014937372,0.0009649331,0.00021372057,0.00062560773,0.0002853103,0.0011599853],"category_scores_gemma":[0.0049508624,0.00027732656,0.00011665439,0.00030194136,0.00042870344,0.00028449847,0.00021481651,0.0007325869,0.0012757207],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002118153,0.000100319754,0.24653725,0.00007818776,0.00010648712,8.952654e-7,0.0050112214,0.000018484334,9.308174e-8,0.6632511,0.05960872,0.025266046],"study_design_scores_gemma":[0.0021306556,0.0005120933,0.028274586,0.000032570937,0.0000026313824,0.0000033708088,0.042253,0.004066868,9.0022485e-7,0.03797154,0.88435173,0.00040004574],"about_ca_topic_score_codex":0.03572218,"about_ca_topic_score_gemma":0.10434525,"teacher_disagreement_score":0.82474303,"about_ca_system_score_codex":0.002483063,"about_ca_system_score_gemma":0.0017724846,"threshold_uncertainty_score":0.9999679},"labels":[],"label_agreement":null},{"id":"W2025067392","doi":"10.2147/ceor.s77175","title":"Inpatient cost of treating osteoporotic fractures in mainland China: a descriptive analysis","year":2015,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"Peking Union Medical College Hospital; Eli Lilly and Company","keywords":"Medicine; Osteoporosis; Hip fracture; Incidence (geometry); Diagnosis code; Emergency medicine; Mainland China; Population; Pediatrics; Demography; Physical therapy; China; Internal medicine; Environmental health","score_opus":0.12633890261137964,"score_gpt":0.4744187474882849,"score_spread":0.34807984487690524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025067392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936203,0.00053707074,0.000012781008,0.0014684489,0.00006092908,0.0009774581,0.00003295889,0.0000070424176,0.00328306],"genre_scores_gemma":[0.99806947,0.00047415396,0.00052289397,0.00018223673,0.00004117514,0.00006508873,0.00004266956,0.00001989339,0.00058240426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973803,0.00028259837,0.0008850399,0.00042713797,0.00040600012,0.0006189253],"domain_scores_gemma":[0.9975704,0.0008864047,0.00015124504,0.0004212248,0.00031067376,0.00066005957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040850653,0.00015742234,0.0009618111,0.0011547945,0.0000845368,0.000044803095,0.00014073552,0.00017445012,0.00008730392],"category_scores_gemma":[0.0018266516,0.00012414617,0.0001619834,0.00071913196,0.00028808674,0.000093205854,0.00019534762,0.00073383853,0.000018048375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000620009,0.00023210839,0.9700861,0.00010593173,0.00016406225,0.000020839281,0.0023032976,0.00007287133,0.000009543422,0.00010059144,0.00018048941,0.02610414],"study_design_scores_gemma":[0.0037156567,0.00086576166,0.9858742,0.000048119502,0.00006927859,0.0000043504056,0.0036836418,0.004497232,0.00007755757,0.00039884672,0.00066145434,0.000103896964],"about_ca_topic_score_codex":0.002347006,"about_ca_topic_score_gemma":0.0018389912,"teacher_disagreement_score":0.026000243,"about_ca_system_score_codex":0.0003159698,"about_ca_system_score_gemma":0.0006764126,"threshold_uncertainty_score":0.5062534},"labels":[],"label_agreement":null},{"id":"W2029722120","doi":"10.2147/ceor.s14404","title":"Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application","year":2011,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Transferability; Checklist; Computer science; Data science; Health care; Medicine; Management science; Machine learning; Psychology; Engineering","score_opus":0.8234713682036561,"score_gpt":0.6793536527463534,"score_spread":0.14411771545730268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029722120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037930082,0.98157823,0.0017545742,0.0027508242,0.00012319985,0.012101964,0.0011245897,0.00001418105,0.00017316236],"genre_scores_gemma":[0.00084934855,0.9917564,0.00308299,0.00028038156,0.000032347405,0.0037450572,0.00013784757,0.000061244384,0.000054383185],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9845412,0.0016244607,0.012038413,0.001219108,0.00009514935,0.00048169054],"domain_scores_gemma":[0.98546296,0.0065638153,0.006447244,0.0011724423,0.00015855039,0.00019500408],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0818163,0.00041407405,0.008885076,0.0010464389,0.00022377542,0.00005513653,0.0004892036,0.00046181298,0.000029815532],"category_scores_gemma":[0.0025631397,0.00042534986,0.00040169552,0.00018105228,0.0005453513,0.00022068892,0.00021642291,0.00046395793,0.000019311876],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000029320893,0.000094451214,0.002764978,0.7859786,0.00036957045,1.4973352e-8,0.000109930224,3.972327e-7,2.9676106e-9,0.14940979,0.0000642062,0.0612051],"study_design_scores_gemma":[0.0049198046,0.0026535315,0.0072055655,0.5835488,0.0019414107,0.000039358,0.003354142,0.010113448,3.2052685e-7,0.19851585,0.18497796,0.0027298399],"about_ca_topic_score_codex":0.00022007804,"about_ca_topic_score_gemma":0.0000701623,"teacher_disagreement_score":0.20242985,"about_ca_system_score_codex":0.00081897574,"about_ca_system_score_gemma":0.0013979494,"threshold_uncertainty_score":0.9998198},"labels":[],"label_agreement":null},{"id":"W2031300497","doi":"10.2147/ceor.s24192","title":"Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Obesity and Health Practices","field":"Health Professions","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McMaster University; University of Alberta; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"Pfizer Canada; Ontario Ministry of Health and Long-Term Care; Pfizer","keywords":"Medicine; Underweight; Overweight; Body mass index; Obesity; Medical record; Public health; Gerontology; Demography; Environmental health; Internal medicine","score_opus":0.1073500015138216,"score_gpt":0.48651171518872527,"score_spread":0.3791617136749037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031300497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872924,0.00063146465,0.0000068523973,0.0069501298,0.00034064354,0.001383074,0.00011488632,0.000017266382,0.0032632716],"genre_scores_gemma":[0.99046195,0.0012282106,0.000067962756,0.0047693695,0.00009155352,0.000096874326,0.00007822205,0.00003332206,0.0031725378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957953,0.0011963373,0.00081549626,0.00038312667,0.00027996564,0.0015297394],"domain_scores_gemma":[0.99451584,0.0039223204,0.0004282346,0.00027039554,0.00018066246,0.00068258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005629155,0.00019198524,0.00061872584,0.00019576555,0.0012285169,0.00005294902,0.00015265269,0.00022261452,0.00018405337],"category_scores_gemma":[0.0010433258,0.00016815787,0.000019879357,0.0001842408,0.00013647786,0.0005053741,0.0001718084,0.0018311728,0.000020588406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004321892,0.00012667166,0.9902799,0.0002162298,0.00004203799,0.0000016008553,0.001702198,0.000002236085,2.050402e-7,0.0016824524,0.0045445296,0.0013587336],"study_design_scores_gemma":[0.0015017681,0.00013010342,0.9625918,0.00025020348,0.000005798377,2.2462088e-7,0.00427711,0.000113241105,2.2891602e-7,0.00019795028,0.030758454,0.00017309091],"about_ca_topic_score_codex":0.9231342,"about_ca_topic_score_gemma":0.9985225,"teacher_disagreement_score":0.075388275,"about_ca_system_score_codex":0.002805484,"about_ca_system_score_gemma":0.011770821,"threshold_uncertainty_score":0.9938315},"labels":[],"label_agreement":null},{"id":"W2032696995","doi":"10.2147/ceor.s33390","title":"Economic analysis of Heart and Stroke Foundation of Ontario's Hypertension Management Initiative","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; University Health Network; University of Toronto; Heart and Stroke Foundation; Sunnybrook Health Science Centre; Toronto Public Health; Health Sciences Centre","funders":"University of Toronto; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"Medicine; Life expectancy; Cohort; Framingham Risk Score; Health care; Stroke (engine); Blood pressure; Emergency medicine; Cohort study; Disease; Gerontology; Population; Internal medicine; Environmental health","score_opus":0.2059208196476358,"score_gpt":0.4375019505193778,"score_spread":0.23158113087174198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032696995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447024,0.0011148168,0.000004863261,0.0009025558,0.00009676001,0.00025250265,0.000019327163,0.0000043553678,0.003134567],"genre_scores_gemma":[0.9951506,0.0015491289,0.0012304133,0.0005313871,0.000035890997,0.000009145645,0.000023054068,0.000009337013,0.0014610232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886644,0.000055116823,0.0005021241,0.00022603349,0.00011963143,0.00023062657],"domain_scores_gemma":[0.9987045,0.0006332528,0.00011861004,0.00027899185,0.00013719405,0.00012747916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012563108,0.00010424911,0.0009335846,0.00051014073,0.00008362031,0.000013824351,0.00004703541,0.00007553293,0.00015927138],"category_scores_gemma":[0.00005097651,0.00008560682,0.00014596173,0.00008873856,0.00022273778,0.000109934794,0.0002203077,0.00017652087,0.000015510532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014231133,0.00013589271,0.98860216,0.000071463655,0.0034039924,6.422014e-7,0.000833038,0.0000037358438,0.00014327635,0.00093164545,0.0005335643,0.0051982603],"study_design_scores_gemma":[0.0010365706,0.00012766894,0.9647088,0.00001881259,0.0017453937,0.0000033006168,0.0006457147,0.00014194104,0.00010785518,0.000082474864,0.03130824,0.000073239324],"about_ca_topic_score_codex":0.0020637282,"about_ca_topic_score_gemma":0.0033870805,"teacher_disagreement_score":0.030774677,"about_ca_system_score_codex":0.00005181865,"about_ca_system_score_gemma":0.00008233842,"threshold_uncertainty_score":0.3490945},"labels":[],"label_agreement":null},{"id":"W2048536877","doi":"10.2147/ceor.s65900","title":"Clinical response and hospital costs associated with the empirical use of vancomycin and linezolid for hospital-acquired pneumonia in a Chinese tertiary care hospital: a retrospective cohort study","year":2014,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Nosocomial Infections in ICU","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); Public Health Ontario; University of Toronto","funders":"Eli Lilly and Company","keywords":"Medicine; Vancomycin; Propensity score matching; Linezolid; Odds ratio; Retrospective cohort study; Pneumonia; Internal medicine; Intensive care medicine; Emergency medicine; Staphylococcus aureus","score_opus":0.06662898276258017,"score_gpt":0.45105435848140235,"score_spread":0.3844253757188222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048536877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904445,0.00013040766,0.000008537829,0.004483591,0.00026267787,0.004553299,0.00006686407,0.000026349424,0.00002379171],"genre_scores_gemma":[0.99856186,0.0003363645,0.00021054264,0.0002895854,0.000114899485,0.00032485553,0.000016648613,0.000057726284,0.00008751851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966636,0.00088818255,0.0009491358,0.000796146,0.0002546142,0.0004483723],"domain_scores_gemma":[0.98735124,0.010919257,0.00027874674,0.00063554203,0.00056942995,0.00024580932],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00572382,0.00028775976,0.0011930553,0.00027605752,0.00023882752,0.0001261957,0.00016376436,0.0002657077,0.0000034657419],"category_scores_gemma":[0.011853628,0.00019041152,0.0001356847,0.00027715607,0.0010230574,0.00017163555,0.00036440004,0.00070827093,0.0000011407379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011541387,0.0011275328,0.9923234,0.00003073648,0.00030294675,0.000011768285,0.0023737324,0.0000012842381,0.000011374256,0.000017844903,0.00040375066,0.0022414762],"study_design_scores_gemma":[0.007188779,0.00919311,0.98051226,0.000079177094,0.00009435847,0.0000033850938,0.0019105407,0.00040466216,0.0000069007515,0.0000951841,0.0002816199,0.0002300508],"about_ca_topic_score_codex":0.00022872313,"about_ca_topic_score_gemma":0.0008932697,"teacher_disagreement_score":0.011811183,"about_ca_system_score_codex":0.00031002858,"about_ca_system_score_gemma":0.00019965437,"threshold_uncertainty_score":0.99647},"labels":[],"label_agreement":null},{"id":"W2055992137","doi":"10.2147/ceor.s29347","title":"Two-factor theory – at the intersection of health care management and patient satisfaction","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Customer Service Quality and Loyalty","field":"Business, Management and Accounting","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Logistic regression; Health care; Intersection (aeronautics); Behavioral Risk Factor Surveillance System; Job satisfaction; Factor (programming language); Psychology; Medicine; Applied psychology; Environmental health; Social psychology; Statistics; Nursing; Mathematics; Computer science; Public health; Engineering; Transport engineering","score_opus":0.09154446576835726,"score_gpt":0.4045769837691336,"score_spread":0.31303251800077636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055992137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926169,0.0012190588,0.000016380163,0.0014138519,0.00049850566,0.0003872653,0.000009393781,0.000014661837,0.0038240128],"genre_scores_gemma":[0.9976376,0.00022004356,0.00004238611,0.0015820736,0.00015167899,0.000018971246,0.0000125413735,0.000014154441,0.00032050457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987665,0.00012323691,0.00042860094,0.000212351,0.00014957962,0.00031973267],"domain_scores_gemma":[0.99905664,0.00034476697,0.00021631345,0.00027452977,0.00007745189,0.00003029574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020622825,0.000111563146,0.00023087641,0.00014903917,0.0004220403,0.00011411706,0.00009196921,0.000045509627,0.00020832568],"category_scores_gemma":[0.00004749616,0.000081362334,0.000063559084,0.00010392382,0.00014522359,0.0003690633,0.00053242326,0.00019938384,0.000087937755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075848795,0.000033142773,0.5720962,0.00033030732,0.000055316086,9.526759e-8,0.0022326268,0.0000034427806,0.0000023045636,0.026548848,0.00054198084,0.39807987],"study_design_scores_gemma":[0.0004888675,0.000023015175,0.9171593,0.000020359215,0.000014749552,6.613652e-7,0.01380852,0.0000357256,0.0000045426646,0.0016533385,0.06668816,0.00010275339],"about_ca_topic_score_codex":0.0015214799,"about_ca_topic_score_gemma":0.0027974448,"teacher_disagreement_score":0.3979771,"about_ca_system_score_codex":0.00013166509,"about_ca_system_score_gemma":0.000013989738,"threshold_uncertainty_score":0.33178595},"labels":[],"label_agreement":null},{"id":"W2060950787","doi":"10.2147/ceor.s30857","title":"The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Heparin; Stroke (engine); Low molecular weight heparin; Intensive care medicine; Venous thromboembolism; Anticoagulant; Acute stroke; Emergency medicine; Internal medicine; Thrombosis","score_opus":0.07582140553644204,"score_gpt":0.46221919055001714,"score_spread":0.38639778501357513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060950787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960004,0.00022776032,0.0000035499434,0.00013713787,0.00041001753,0.0011496248,0.000075138036,0.0000051942457,0.0019911749],"genre_scores_gemma":[0.9961964,0.0031376563,0.00011071159,0.000014921986,0.00006645477,0.00009360822,0.000053141495,0.00002283147,0.0003042709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984293,0.000070606424,0.00069806684,0.00021828827,0.00012307634,0.00046065342],"domain_scores_gemma":[0.99797344,0.0011844322,0.00025994654,0.00033965675,0.00011778319,0.00012472774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015270009,0.00013410325,0.00072336296,0.0002100237,0.000100941936,0.000021543172,0.00015748182,0.00011309994,0.00006234323],"category_scores_gemma":[0.00021512966,0.000100675104,0.0002628178,0.0000622506,0.00016629139,0.00014710045,0.00016241611,0.00022753426,0.00001589758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020564024,0.0018410059,0.79994106,0.00016054326,0.0019382088,3.6096299e-7,0.0005363172,0.00011845103,0.00024637126,0.0021491933,0.0036328735,0.18737918],"study_design_scores_gemma":[0.004717903,0.0014788455,0.9891318,0.00002537839,0.0001174424,4.2748172e-7,0.00021733176,0.0006090011,0.0004359428,0.00018889632,0.0029890486,0.0000879536],"about_ca_topic_score_codex":0.00043038942,"about_ca_topic_score_gemma":0.00016823183,"teacher_disagreement_score":0.18919075,"about_ca_system_score_codex":0.0005153947,"about_ca_system_score_gemma":0.00023935371,"threshold_uncertainty_score":0.41054115},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2091242733","doi":"10.2147/ceor.s31552","title":"Techniques for estimating health care costs with censored data: an overview for the health services researcher","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Public Health; Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Estimator; Activity-based costing; Censoring (clinical trials); Medicine; Statistics; Health care; Health economics; Sample (material); Econometrics; Actuarial science; Mathematics; Economics; Public health; Business; Marketing; Nursing","score_opus":0.7588877606600927,"score_gpt":0.6583699927180167,"score_spread":0.10051776794207601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091242733","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15261158,0.22589445,0.037888307,0.5201846,0.0029873804,0.037602767,0.021336643,0.00041792862,0.0010763854],"genre_scores_gemma":[0.24653153,0.019512594,0.6211702,0.09698795,0.005297532,0.005241676,0.003619036,0.0005227011,0.0011167839],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935104,0.00072525383,0.0032067879,0.0009857588,0.00014995412,0.0014217907],"domain_scores_gemma":[0.9867666,0.008965235,0.0015807535,0.001773719,0.00025920288,0.00065451866],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.07628769,0.00026890854,0.0013746151,0.00032023087,0.0014613416,0.0004095576,0.0011225721,0.00016251941,0.000035485573],"category_scores_gemma":[0.001948891,0.00023118769,0.00011405007,0.00015550158,0.00024534392,0.0011643358,0.00039012067,0.0004419984,0.00005339287],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004972017,0.00053293124,0.3503268,0.012739433,0.0005652529,2.572161e-7,0.02527662,0.00006743601,2.3986368e-7,0.3959289,0.04813819,0.16592674],"study_design_scores_gemma":[0.003695009,0.0022694832,0.07795582,0.0005821424,0.000018843419,0.000007707991,0.042423375,0.07904115,0.0000024804442,0.008097145,0.7850037,0.0009031083],"about_ca_topic_score_codex":0.0037842814,"about_ca_topic_score_gemma":0.0034405573,"teacher_disagreement_score":0.7368655,"about_ca_system_score_codex":0.0010386258,"about_ca_system_score_gemma":0.00074806385,"threshold_uncertainty_score":0.9998386},"labels":[],"label_agreement":null},{"id":"W2094630798","doi":"10.2147/ceor.s37205","title":"Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection","year":2012,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa","funders":"","keywords":"Boceprevir; Telaprevir; Medicine; Ribavirin; Pegylated interferon; Internal medicine; Gastroenterology; Virology; Hepatitis C virus; Virus","score_opus":0.13712591260711343,"score_gpt":0.5096281915013214,"score_spread":0.372502278894208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094630798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941867,0.0038414758,0.000058871905,0.00036858866,0.000058777237,0.0009761065,0.00015679916,0.000004688742,0.00034800833],"genre_scores_gemma":[0.9328145,0.06644403,0.00018076313,0.000033305885,0.00007695799,0.00007934005,0.00002808023,0.000016461829,0.00032656442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986022,0.000135284,0.0005168751,0.00020905121,0.00016734489,0.00036921096],"domain_scores_gemma":[0.9958997,0.0031143455,0.00011946065,0.0004288426,0.00022535703,0.00021233148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020248776,0.000121202946,0.0007429788,0.00047720748,0.00011209676,0.00002409133,0.00007196111,0.00010292115,0.00017045623],"category_scores_gemma":[0.0005990708,0.000074094554,0.00034484855,0.0003230395,0.00032001873,0.00009071988,0.00006712731,0.00013751382,0.000005744812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014463665,0.0002141808,0.82416564,0.00007603166,0.0017062814,2.3136704e-7,0.00036853,0.000008143204,0.000065959706,0.00015812194,0.00008328311,0.17300895],"study_design_scores_gemma":[0.0010611048,0.0013786869,0.9797114,0.000009723648,0.0005844001,9.649866e-7,0.000040501316,0.0047872313,0.00027619122,0.00004831898,0.0120409895,0.000060486036],"about_ca_topic_score_codex":0.0031490591,"about_ca_topic_score_gemma":0.000566928,"teacher_disagreement_score":0.17294846,"about_ca_system_score_codex":0.00014505441,"about_ca_system_score_gemma":0.00012345107,"threshold_uncertainty_score":0.47604567},"labels":[],"label_agreement":null},{"id":"W2136904329","doi":"10.2147/ceor.s85635","title":"Review of the cost of venous thromboembolism","year":2015,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pulmonary embolism; Venous thromboembolism; Population; Emergency medicine; Incidence (geometry); MEDLINE; Total cost; Indirect costs; Intensive care medicine; Pediatrics; Surgery; Environmental health; Thrombosis","score_opus":0.28277643727394947,"score_gpt":0.5420026030179217,"score_spread":0.2592261657439722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136904329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009811774,0.9866864,3.392788e-7,0.0005576007,0.00043185026,0.0037617704,0.00011078454,0.0000070685255,0.008346048],"genre_scores_gemma":[0.000028978917,0.998324,0.00004404253,0.00068763155,0.00011956482,0.00015566275,0.000039286293,0.00006022823,0.0005406175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966302,0.00038850738,0.0017043798,0.00046180532,0.00040334897,0.0004117681],"domain_scores_gemma":[0.9962611,0.00091626326,0.00078467233,0.0013812529,0.0004385298,0.00021818523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004783149,0.0003175129,0.0060509983,0.0002543374,0.00007914384,0.000018832738,0.0006201934,0.0002794544,0.00013605157],"category_scores_gemma":[0.00086452893,0.00018816172,0.000972308,0.0003171746,0.0005555026,0.000035388646,0.0009162112,0.0008084889,0.000051423052],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000032721096,0.00037421327,0.00013818139,0.17552878,0.00050957827,0.0000020176328,0.000037896476,6.653684e-8,1.9382762e-8,0.0010843687,0.018844273,0.80347735],"study_design_scores_gemma":[0.00036224525,0.00023156458,0.0013378456,0.07668993,0.0013203457,0.00001072997,0.00003547456,0.0000016963573,3.9290865e-7,0.00016338644,0.9197093,0.00013706247],"about_ca_topic_score_codex":0.00007958217,"about_ca_topic_score_gemma":0.0000108904005,"teacher_disagreement_score":0.9008651,"about_ca_system_score_codex":0.00016958796,"about_ca_system_score_gemma":0.0012752967,"threshold_uncertainty_score":0.7673012},"labels":[],"label_agreement":null},{"id":"W2147808981","doi":"10.2147/ceor.s61602","title":"Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review","year":2014,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Laxative; Medicine; Constipation; Bloating; Defecation; Tegaserod; Irritable bowel syndrome; Cathartic; Medical prescription; Flatulence; Physical therapy; Internal medicine; Abdominal pain; Pharmacology","score_opus":0.03591146050078674,"score_gpt":0.34550008038958596,"score_spread":0.3095886198887992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147808981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522316,0.0005091473,0.000013547483,0.0030140346,0.000022071768,0.0010961215,0.000021818523,0.0000015148582,0.00009860004],"genre_scores_gemma":[0.9973976,0.00088518707,0.000036797057,0.0015714292,0.0000073717083,0.000052728363,0.00002479131,0.000006766258,0.000017310782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979217,0.0005941581,0.0006594124,0.0003266083,0.00025346605,0.00024465096],"domain_scores_gemma":[0.99659806,0.002535633,0.00022831604,0.0003282225,0.00022784625,0.000081917424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005068082,0.00013938302,0.0007733853,0.00020281391,0.000079542246,0.000021946778,0.000086809996,0.000043284315,0.000029015704],"category_scores_gemma":[0.0036334556,0.000077309,0.000059395203,0.00033687102,0.00038834248,0.00005205503,0.00006570036,0.0003765147,2.788594e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029042162,0.000067507826,0.99081916,0.00011781027,0.00015261136,0.000001796826,0.00031148046,0.000005250583,4.740394e-7,0.00012103274,0.000048325524,0.00806414],"study_design_scores_gemma":[0.0041422127,0.00055745535,0.99168044,0.0002357776,0.00017884046,9.2280703e-7,0.00035423826,0.0026666452,7.237773e-7,0.00005670287,0.00005740177,0.00006863025],"about_ca_topic_score_codex":0.102255754,"about_ca_topic_score_gemma":0.6103207,"teacher_disagreement_score":0.5080649,"about_ca_system_score_codex":0.00018850052,"about_ca_system_score_gemma":0.00033437015,"threshold_uncertainty_score":0.9037224},"labels":[],"label_agreement":null},{"id":"W2320400291","doi":"10.2147/ceor.s101013","title":"Designing economic evaluations to facilitate optimal decisions: the need to avoid bias","year":2016,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Agency (philosophy); Argument (complex analysis); Economic evaluation; Actuarial science; External validity; Public economics; Medicine; Operations research; Positive economics; Economics; Sociology; Psychology; Social science; Microeconomics; Social psychology; Engineering","score_opus":0.8023725701622225,"score_gpt":0.5985496615594716,"score_spread":0.20382290860275087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320400291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73212314,0.0004960037,0.017489366,0.24379957,0.0009385464,0.0023007933,0.0006054947,0.00005406107,0.0021930186],"genre_scores_gemma":[0.9399725,0.0011449051,0.016795939,0.027644342,0.00071796286,0.0012356734,0.000019156367,0.00013792515,0.012331555],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99144477,0.0010935023,0.0048104413,0.0013319761,0.00018474318,0.0011345947],"domain_scores_gemma":[0.9696142,0.027077613,0.0007738324,0.00147217,0.00019132349,0.00087086606],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch","insufficient_payload"],"category_scores_codex":[0.06586735,0.00034056822,0.0012775683,0.0010650895,0.0009386404,0.0004734412,0.0010621635,0.00020975588,0.00094071287],"category_scores_gemma":[0.030466693,0.00027176295,0.0002617807,0.00027774865,0.00027563877,0.0005595845,0.00062963035,0.000395316,0.026964929],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042930656,0.0002576804,0.41876885,0.00012802272,0.00062341744,0.000004142852,0.013666242,0.011898659,0.000082205006,0.25363705,0.2565783,0.04392614],"study_design_scores_gemma":[0.0046637254,0.001147246,0.21139051,0.0003680417,0.000027129856,0.000014008091,0.011455151,0.011167118,0.00008456339,0.096946284,0.66096205,0.0017741519],"about_ca_topic_score_codex":0.0006198162,"about_ca_topic_score_gemma":0.00049662427,"teacher_disagreement_score":0.40438378,"about_ca_system_score_codex":0.0012302013,"about_ca_system_score_gemma":0.0005064451,"threshold_uncertainty_score":0.9999735},"labels":[],"label_agreement":null},{"id":"W2346242965","doi":"10.2147/ceor.s104195","title":"Cost-effectiveness of bortezomib for multiple myeloma: a systematic review","year":2016,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bortezomib; Multiple myeloma; Thalidomide; Lenalidomide; Cost effectiveness; Melphalan; Internal medicine; Oncology","score_opus":0.3310564834221789,"score_gpt":0.560687487546833,"score_spread":0.22963100412465404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346242965","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005280172,0.9698036,0.00003299305,0.00009439546,0.00013266734,0.028781474,0.0008450636,0.000019702873,0.00023730981],"genre_scores_gemma":[0.00011698011,0.9898115,0.00020080598,0.000046411416,0.00007817456,0.008001998,0.00029630688,0.000116860174,0.0013309879],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9944742,0.0013108791,0.0020918471,0.0008829225,0.00040106341,0.00083913445],"domain_scores_gemma":[0.9712209,0.02577631,0.0006252524,0.0012610591,0.00058913406,0.0005273445],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008616997,0.0005363105,0.00791758,0.000582984,0.00014681483,0.000048835012,0.00043707245,0.00041835543,0.00005264249],"category_scores_gemma":[0.009803297,0.00031098793,0.0015448933,0.00021711842,0.00036254356,0.00007819619,0.00034577257,0.0005818749,0.00016379493],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001337845,0.00015670541,0.0005765875,0.7167809,0.0013358754,0.000015113579,0.000004250833,4.227531e-9,1.6124623e-7,0.00014866404,0.00012947804,0.28071845],"study_design_scores_gemma":[0.0047378154,0.0006481762,0.00046656988,0.8115968,0.002016767,0.00005442531,0.0000135918635,0.000025118085,0.0000029302996,0.000106925596,0.18000796,0.00032293165],"about_ca_topic_score_codex":0.000018153329,"about_ca_topic_score_gemma":0.000008191802,"teacher_disagreement_score":0.28039554,"about_ca_system_score_codex":0.00046669258,"about_ca_system_score_gemma":0.0011313892,"threshold_uncertainty_score":0.9999342},"labels":[],"label_agreement":null},{"id":"W2403025629","doi":"10.2147/ceor.s102243","title":"The changing landscape of antiviral treatment of herpes zoster: a 17-year population-based cohort study","year":2016,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Famciclovir; Rash; Medical prescription; Incidence (geometry); Population; Antiviral treatment; Antiviral therapy; Observational study; Shingles; Cohort; Pediatrics; Internal medicine; Immunology; Virus; Pharmacology; Environmental health","score_opus":0.060994089739721286,"score_gpt":0.424700146291634,"score_spread":0.3637060565519127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403025629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975814,0.00008902088,0.000004003048,0.00051506294,0.00007551363,0.00079423597,0.000026993624,0.000007460109,0.000906259],"genre_scores_gemma":[0.99776644,0.0004233024,0.000035167373,0.000013793756,0.000039362625,0.000057548106,0.0000057477423,0.000012955094,0.0016456901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894994,0.00009748597,0.00039658896,0.00020204045,0.00012756232,0.00022635197],"domain_scores_gemma":[0.998147,0.0012450917,0.000099088524,0.00035217652,0.000094493735,0.000062116946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008784723,0.00009645643,0.00039279228,0.00019945088,0.00015641082,0.000017438037,0.000053567554,0.000048986964,0.00005360127],"category_scores_gemma":[0.00009820523,0.000047099355,0.00011688907,0.000098574565,0.0001068651,0.00003354091,0.000037439382,0.00004154095,0.000011738908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013692945,0.00057077815,0.85469484,0.000008078119,0.00024216942,0.0000021583783,0.00009804378,5.5611224e-7,0.0000031053357,0.00007902953,0.0000136549625,0.14415064],"study_design_scores_gemma":[0.004058295,0.0012707149,0.99142563,0.000026583442,0.00005481557,5.8550347e-7,0.0004005723,0.00011432913,0.0001414111,0.00005402182,0.0024058025,0.000047207537],"about_ca_topic_score_codex":0.00026201014,"about_ca_topic_score_gemma":0.00021242374,"teacher_disagreement_score":0.14410344,"about_ca_system_score_codex":0.000075946904,"about_ca_system_score_gemma":0.00008287115,"threshold_uncertainty_score":0.1920656},"labels":[],"label_agreement":null},{"id":"W2419019628","doi":"10.2147/ceor.s105579","title":"Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK","year":2016,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; COPD; Tiotropium bromide; Lama; Bronchodilator; Obstructive lung disease; Cohort; Glycopyrrolate; Cost effectiveness; Clinical trial; Lung function; Physical therapy; Internal medicine; Intensive care medicine; Emergency medicine; Lung; Asthma","score_opus":0.05920928524898796,"score_gpt":0.37782531472878655,"score_spread":0.3186160294797986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419019628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903921,0.0018442032,0.00000883943,0.0040291753,0.00025490188,0.0026857522,0.00024193751,0.0000059515137,0.0005371394],"genre_scores_gemma":[0.9977402,0.001248637,0.000019349693,0.00008373043,0.00008653929,0.0003452101,0.00001590509,0.000039809223,0.00042063775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99647486,0.00078650546,0.0006523074,0.00078943174,0.00043817837,0.00085872295],"domain_scores_gemma":[0.99310374,0.005288858,0.00009167309,0.00066197495,0.00023781297,0.0006159563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022224041,0.00027432895,0.0008597248,0.00041299948,0.00011802937,0.000039046598,0.00030896763,0.00010593205,0.000113001945],"category_scores_gemma":[0.0011020004,0.00018354302,0.00011221204,0.00030845052,0.0008709852,0.00015647087,0.00061595574,0.00059981045,0.0000129154105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031132877,0.00010913293,0.93382734,0.00063694734,0.00010541909,0.00025950064,0.0000835993,0.00027857255,0.000088914654,0.0016390149,0.000035004854,0.031803682],"study_design_scores_gemma":[0.0134392865,0.00012867006,0.979838,0.000304267,0.000024225834,0.000009358617,0.0004908287,0.0039767637,0.000065486216,0.001278994,0.00023469873,0.00020938055],"about_ca_topic_score_codex":0.13304825,"about_ca_topic_score_gemma":0.25348243,"teacher_disagreement_score":0.120434195,"about_ca_system_score_codex":0.004319924,"about_ca_system_score_gemma":0.005033746,"threshold_uncertainty_score":0.9995023},"labels":[],"label_agreement":null},{"id":"W2517422947","doi":"10.2147/ceor.s96616","title":"Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders","year":2016,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Global Affairs Canada; MaRS; University of Ottawa","funders":"","keywords":"Government (linguistics); Listing (finance); Medicine; Phone; Product (mathematics); Pharmacy; Health care; Griffin; Public relations; Political science; Library science; Family medicine; Business; Finance; Law","score_opus":0.6820703392903806,"score_gpt":0.5586353996660185,"score_spread":0.12343493962436214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517422947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676246,0.0005721167,0.00013626114,0.028486852,0.0010310966,0.00075379,0.0008314437,0.000010741499,0.00055309926],"genre_scores_gemma":[0.99453247,0.0006937499,0.002277298,0.0018373005,0.000113704584,0.00003515521,0.000054357966,0.00003862763,0.0004173694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944673,0.00045393468,0.0036122573,0.00075793685,0.00009569607,0.00061283296],"domain_scores_gemma":[0.9938717,0.003434128,0.0015082288,0.00038427341,0.00050919096,0.0002924896],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.023349583,0.00021194323,0.000963715,0.0014861661,0.0002843847,0.00012073398,0.00030729978,0.00013307136,0.00012266643],"category_scores_gemma":[0.020535564,0.00020132597,0.000063070205,0.0003479613,0.00037113225,0.0005223197,0.00025235285,0.00025435994,0.000052681662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019561614,0.000034637123,0.9900529,0.00007120847,0.00014170453,2.4237517e-7,0.0016290852,0.0000112850585,0.000015757276,0.004139528,0.00080547616,0.003078631],"study_design_scores_gemma":[0.0015974877,0.0001299558,0.9736691,0.00011892668,0.000002621802,0.0000016775216,0.0029829266,0.0055662603,0.000011491545,0.0020200554,0.013503751,0.00039575857],"about_ca_topic_score_codex":0.11281845,"about_ca_topic_score_gemma":0.020268425,"teacher_disagreement_score":0.092550024,"about_ca_system_score_codex":0.0008211919,"about_ca_system_score_gemma":0.0006406126,"threshold_uncertainty_score":0.99760914},"labels":[],"label_agreement":null},{"id":"W2523705911","doi":"10.2147/ceor.s113559","title":"Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand","year":2016,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Ottawa Hospital","funders":"","keywords":"Medicine; Dipeptidyl peptidase-4 inhibitor; Cost effectiveness; Type 2 diabetes; Tolerability; Hypoglycemia; Metformin; Type 2 Diabetes Mellitus; Incremental cost-effectiveness ratio; Population; Internal medicine; Diabetes mellitus; Cost-effectiveness analysis; Insulin; Endocrinology; Adverse effect; Environmental health","score_opus":0.0753620826860664,"score_gpt":0.40364102088506476,"score_spread":0.32827893819899834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523705911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972833,0.00015217028,9.084947e-7,0.00033459743,0.00011598954,0.001234089,0.000013989867,0.0000070205588,0.0008579651],"genre_scores_gemma":[0.9978951,0.001198415,0.000043223612,0.00006476018,0.000021951717,0.000098047014,0.000015324353,0.000020874915,0.00064226065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986121,0.00016235988,0.00040919142,0.00032017133,0.00012876572,0.00036741543],"domain_scores_gemma":[0.99805826,0.0014286812,0.00006327723,0.00026277662,0.00008843459,0.00009855108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014475388,0.00013209575,0.00051412417,0.00041178343,0.000022012346,0.000018975214,0.0000936349,0.00009058519,0.000049643964],"category_scores_gemma":[0.00022008453,0.000087146145,0.00006585499,0.00014791086,0.00014131538,0.00010789871,0.000099961886,0.00012328695,0.000025261113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042766065,0.00045585053,0.8862847,0.000108835746,0.000060766382,0.0000028942957,0.00006757942,7.3906705e-7,0.00018049651,0.000137585,0.0000827119,0.11219015],"study_design_scores_gemma":[0.010287083,0.0012868684,0.98501927,0.00031455653,0.000008699039,3.7392017e-8,0.000050634957,0.00003279942,0.00092872104,0.00051846704,0.0014566798,0.000096214826],"about_ca_topic_score_codex":0.00004676778,"about_ca_topic_score_gemma":0.00015314565,"teacher_disagreement_score":0.11209393,"about_ca_system_score_codex":0.00015862069,"about_ca_system_score_gemma":0.00005653541,"threshold_uncertainty_score":0.35537165},"labels":[],"label_agreement":null},{"id":"W2539439489","doi":"10.2147/ceor.s116570","title":"Bringing patient centricity to diabetes medication access in Canada","year":2016,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; Alberta Health; University of Alberta; Alberta Health Services","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Medicine; Diabetes mellitus; Public health; Health care; Gerontology; Rehabilitation; Family medicine; Business; Nursing; Economic growth; Physical therapy","score_opus":0.13138048648490971,"score_gpt":0.4679964293457163,"score_spread":0.33661594286080654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539439489","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034025285,0.9592507,0.000001079257,0.0017344243,0.0004868596,0.0025782369,0.00006361331,0.000019861045,0.0018399749],"genre_scores_gemma":[0.0027743243,0.9955899,0.000028509565,0.00052881095,0.000079679456,0.00026027596,0.000051024705,0.000049923554,0.0006375236],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975073,0.00012566746,0.0008475725,0.0005815908,0.0002726572,0.00066521566],"domain_scores_gemma":[0.9975717,0.0013307381,0.00016774333,0.0004816869,0.000058804155,0.00038930622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000964948,0.000260918,0.0015143955,0.0006552761,0.000064017666,0.000087008455,0.0003092335,0.000112366244,0.00009036872],"category_scores_gemma":[0.00038764902,0.00017961679,0.00015297037,0.00022506794,0.000045221022,0.00007677498,0.00070852,0.00035638883,0.0000854927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000040547206,0.000043972846,0.07636881,0.0025104417,0.00015888391,0.000014067566,0.000011840793,1.814925e-7,6.7393384e-9,0.00005194265,0.0019116168,0.9189242],"study_design_scores_gemma":[0.00052528066,0.000082019826,0.019219605,0.00484715,0.00010238102,4.3405595e-7,0.000025240792,0.00002545063,7.008084e-7,0.000036649646,0.97494704,0.00018807966],"about_ca_topic_score_codex":0.055896387,"about_ca_topic_score_gemma":0.122864656,"teacher_disagreement_score":0.9730354,"about_ca_system_score_codex":0.0021319047,"about_ca_system_score_gemma":0.0016815081,"threshold_uncertainty_score":0.95039046},"labels":[],"label_agreement":null},{"id":"W2570534554","doi":"10.2147/ceor.s126379","title":"Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis","year":2017,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); McMaster University; Augmentium Pharma Consulting (Canada)","funders":"Pfizer","keywords":"Medicine; Low molecular weight heparin; Confidence interval; Population; Relative risk; Randomized controlled trial; Venous thromboembolism; Internal medicine; Heparin; Pediatrics; Intensive care medicine; Thrombosis","score_opus":0.07103644488420478,"score_gpt":0.44294887340268957,"score_spread":0.37191242851848477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570534554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951733,0.0002661089,0.0000033551796,0.0022709146,0.0002381671,0.0015782265,0.00013265699,0.0000030300473,0.0003342574],"genre_scores_gemma":[0.9953944,0.004005991,0.000080872494,0.0000941511,0.000055266304,0.00020832979,0.000041162522,0.000018153882,0.00010167972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860775,0.00004300854,0.00042216742,0.00038876876,0.00011968477,0.00041862685],"domain_scores_gemma":[0.9985963,0.0003592413,0.00022821003,0.0004959259,0.00010945105,0.00021083419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012189228,0.00014608438,0.0007477813,0.0003707666,0.00046674968,0.00012607385,0.0002241926,0.000067167086,0.000046753983],"category_scores_gemma":[0.000080824546,0.000105723135,0.00012222737,0.00007464102,0.00028013068,0.00011395976,0.00015457199,0.00020822027,0.0000016616119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009785003,0.0005508599,0.8863886,0.00011657205,0.0019113377,0.0000018677488,0.000346204,0.00004715225,0.0000020909472,0.0005024245,0.00033405228,0.10882034],"study_design_scores_gemma":[0.0073980126,0.001166167,0.9862873,0.00005064142,0.0006868229,1.4612036e-7,0.00013940618,0.0015521446,0.000017014878,0.0000764221,0.0025142662,0.000111685615],"about_ca_topic_score_codex":0.03183107,"about_ca_topic_score_gemma":0.16849221,"teacher_disagreement_score":0.13666114,"about_ca_system_score_codex":0.00025363683,"about_ca_system_score_gemma":0.00031805018,"threshold_uncertainty_score":0.97461605},"labels":[],"label_agreement":null},{"id":"W2606890206","doi":"10.2147/ceor.s112254","title":"Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom","year":2017,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Allergan; Ipsen","keywords":"Cervical dystonia; Medicine; Cost effectiveness; Spasmodic Torticollis; Quality-adjusted life year; Economic evaluation; Quality of life (healthcare); Cost-effectiveness analysis; Formulary; Botulinum toxin; Physical therapy; Dystonia; Surgery; Family medicine; Psychiatry","score_opus":0.3601731427935707,"score_gpt":0.5331505517367018,"score_spread":0.17297740894313107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606890206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922391,0.0001989787,0.00003801196,0.0058133435,0.00007160595,0.0014070108,0.000032077543,0.0000029335415,0.00019692039],"genre_scores_gemma":[0.99621236,0.0033118657,0.00003068238,0.0002116107,0.000018384462,0.000119197844,0.000014561464,0.000008794737,0.000072556024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870896,0.00024612507,0.00042974026,0.0002487027,0.00012471278,0.00024178407],"domain_scores_gemma":[0.9911517,0.007807834,0.00016081847,0.00070834224,0.00011095887,0.000060332324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019525284,0.00010910859,0.00064108917,0.00027918097,0.00024303257,0.00003635593,0.00033162924,0.00016084453,0.000023769648],"category_scores_gemma":[0.0005460044,0.000050397168,0.00034538668,0.0002477985,0.0006942688,0.00002348529,0.000060825725,0.00025974258,0.0000016624183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013516862,0.0008945674,0.9658248,0.000069549045,0.0013655807,0.0000075054895,0.00048193015,0.00046511827,0.000044141572,0.003985,0.000014302978,0.025495825],"study_design_scores_gemma":[0.0034571155,0.001177439,0.970844,0.000012420907,0.00047483886,9.60213e-7,0.00024870233,0.018997967,0.000066306755,0.00053183024,0.004139221,0.000049252085],"about_ca_topic_score_codex":0.0005841028,"about_ca_topic_score_gemma":0.0002600553,"teacher_disagreement_score":0.025446573,"about_ca_system_score_codex":0.000036031233,"about_ca_system_score_gemma":0.00005431887,"threshold_uncertainty_score":0.25580624},"labels":[],"label_agreement":null},{"id":"W2621729744","doi":"10.2147/ceor.s134230","title":"Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?","year":2017,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Takeda Pharmaceuticals International","keywords":"Orphan drug; Medicine; Oncology; Internal medicine; Pediatric oncology; Health technology; Intensive care medicine; Cancer; Bioinformatics; Health care","score_opus":0.7943854672875345,"score_gpt":0.6411852936115382,"score_spread":0.15320017367599625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621729744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006647517,0.95709777,0.00033422656,0.02696477,0.0016354498,0.007997026,0.0036803447,0.000051185205,0.0021727625],"genre_scores_gemma":[0.00014448991,0.97271967,0.0032974049,0.0011453177,0.0015662062,0.0058414075,0.0006286073,0.00020155194,0.01445536],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98867077,0.0007338448,0.0069301506,0.0021620984,0.00014428151,0.0013588665],"domain_scores_gemma":[0.9571529,0.030073466,0.00960173,0.0019814072,0.00064586184,0.0005446033],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.052577164,0.00072320685,0.0069854124,0.0016244211,0.0017980582,0.0013649769,0.0019952627,0.0010495586,0.0002445779],"category_scores_gemma":[0.028337605,0.0007926109,0.0009866178,0.00021482374,0.00059822545,0.00081583374,0.0004640706,0.001066295,0.0010504418],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004814167,0.00039108348,0.004216288,0.08696077,0.0010821423,0.0000019750166,0.0024823248,0.0000016659832,5.716204e-9,0.086222604,0.4452654,0.37332758],"study_design_scores_gemma":[0.0012377099,0.00014694767,0.00015952304,0.001615301,0.00007243481,0.0000045423935,0.0012837866,0.00016843599,6.607678e-8,0.018715648,0.97584915,0.0007464789],"about_ca_topic_score_codex":0.0001717629,"about_ca_topic_score_gemma":0.0003192947,"teacher_disagreement_score":0.53058374,"about_ca_system_score_codex":0.0020489045,"about_ca_system_score_gemma":0.0031700276,"threshold_uncertainty_score":0.99972737},"labels":[],"label_agreement":null},{"id":"W2742426022","doi":"10.2147/ceor.s139949","title":"The value of corneoscleral rim cultures in keratoplasty: a systematic review and cost-effectiveness analysis","year":2017,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Corneal surgery and disorders","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Western University","funders":"","keywords":"Medicine; Cochrane Library; Endophthalmitis; Meta-analysis; Keratitis; CINAHL; Predictive value; Ophthalmology; Microbiological culture; MEDLINE; Surgery; Internal medicine; Biology; Bacteria","score_opus":0.25716413669056765,"score_gpt":0.5581550544101452,"score_spread":0.3009909177195776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742426022","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011112489,0.9935528,9.023001e-7,0.0001760318,0.000076148695,0.004648552,0.000050198112,0.0000048973175,0.00037920894],"genre_scores_gemma":[0.00096686766,0.99770683,0.0000044512817,0.00009378982,0.000018493623,0.00055015425,0.000038263435,0.000023592052,0.00059755624],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99616265,0.0012970008,0.0014744095,0.0005098775,0.00018165154,0.00037439572],"domain_scores_gemma":[0.98922634,0.008887916,0.0006282951,0.00093170005,0.00014458825,0.00018118105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0086005395,0.00030785144,0.005902974,0.00039024628,0.00025497473,0.00013944853,0.00029905856,0.0002529746,0.000014016929],"category_scores_gemma":[0.0038230573,0.00017177494,0.00084736967,0.00031913104,0.00046096017,0.00005678212,0.00029170903,0.00076947664,0.000009197837],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042531112,0.000074128606,0.020285057,0.7805386,0.0021768983,0.000011781724,0.00002872508,4.7568793e-7,7.2240436e-9,0.0007661059,0.000074388656,0.19600126],"study_design_scores_gemma":[0.0021182103,0.000351152,0.05705287,0.5130514,0.027118541,0.00006426272,0.00021698083,0.0002559292,1.1957862e-7,0.00044926605,0.39856637,0.0007549376],"about_ca_topic_score_codex":0.00016432397,"about_ca_topic_score_gemma":0.00025967142,"teacher_disagreement_score":0.39849195,"about_ca_system_score_codex":0.00010230273,"about_ca_system_score_gemma":0.000406468,"threshold_uncertainty_score":0.7004779},"labels":[],"label_agreement":null},{"id":"W2753175606","doi":"10.2147/ceor.s135445","title":"Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review","year":2017,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Takeda Pharmaceuticals International","keywords":"Estimation; MEDLINE; Medicine; Health technology; Health care; Cochrane Library; Markov model; Agency (philosophy); Actuarial science; Operations research; Markov chain; Computer science; Meta-analysis; Machine learning; Political science; Business; Sociology","score_opus":0.691103139678902,"score_gpt":0.6347797981484892,"score_spread":0.05632334153041285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753175606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028573532,0.97283036,0.00041547505,0.013788572,0.0004356874,0.009255794,0.002907555,0.000008788124,0.00007201854],"genre_scores_gemma":[0.00038731223,0.99211633,0.0030119084,0.0013725917,0.000073400086,0.002228992,0.0007114689,0.000057324,0.000040681414],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9881296,0.001669695,0.008497462,0.0010152933,0.00012912811,0.0005588005],"domain_scores_gemma":[0.97446316,0.020145541,0.0038093699,0.0012500691,0.00020360811,0.00012826361],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.047321193,0.00038926987,0.0042153825,0.0012597209,0.00034231014,0.00029398032,0.0006379703,0.00034976494,0.00004139931],"category_scores_gemma":[0.014478083,0.0003506461,0.0005335059,0.0002841961,0.00016781654,0.00060150406,0.000118834396,0.00104217,0.00002895226],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004019945,0.00019277234,0.001293486,0.12693378,0.00010514796,4.7586917e-7,0.0022016629,0.00040309943,1.0616319e-10,0.0537843,0.0065742037,0.80847085],"study_design_scores_gemma":[0.000879291,0.00020307011,0.001126386,0.19781928,0.00003226128,0.0000025644727,0.0004537067,0.021037115,3.7443013e-9,0.054815657,0.7230678,0.00056286453],"about_ca_topic_score_codex":0.00017885154,"about_ca_topic_score_gemma":0.0006853045,"teacher_disagreement_score":0.807908,"about_ca_system_score_codex":0.0015386393,"about_ca_system_score_gemma":0.0010316246,"threshold_uncertainty_score":0.99989456},"labels":[],"label_agreement":null},{"id":"W2759477597","doi":"10.2147/ceor.s140063","title":"Drug tendering: drug supply and shortage implications for the uptake of biosimilars","year":2017,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"Pfizer","keywords":"Biosimilar; Procurement; Medicine; Economic shortage; Incentive; Health care; Business; Risk analysis (engineering); Pharmacology; Marketing; Economic growth","score_opus":0.38833538714832483,"score_gpt":0.5507725914305369,"score_spread":0.1624372042822121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759477597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012619991,0.99187183,0.000015951438,0.0045688273,0.00042170746,0.0014459578,0.0011045501,0.000009836008,0.0004351621],"genre_scores_gemma":[0.00020485099,0.99202996,0.0005103744,0.00015563631,0.00005970371,0.00019800947,0.00005531219,0.000039379916,0.0067467866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997403,0.00028104603,0.0011116868,0.00064436044,0.000030538875,0.000529324],"domain_scores_gemma":[0.99068266,0.007617261,0.00042195324,0.001072435,0.0001298947,0.000075774165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046970523,0.00032767316,0.0018436365,0.0002062824,0.0007309809,0.00012768651,0.00092335977,0.00051066984,0.00007922841],"category_scores_gemma":[0.0008714309,0.00019341962,0.00059624575,0.000064594904,0.0015870562,0.000050321923,0.00065747276,0.0009168393,0.000009606202],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014740166,0.00004185119,0.001246138,0.0014153086,0.00062333513,2.3957725e-7,0.000033475295,1.6774564e-8,0.000002493656,0.0033004344,0.008085651,0.9852363],"study_design_scores_gemma":[0.00036424075,0.000054083703,0.004243573,0.0003499147,0.0004351274,0.000010211286,0.000089944086,0.0000039058777,0.000007490733,0.0010472784,0.99319214,0.00020211625],"about_ca_topic_score_codex":0.0000235249,"about_ca_topic_score_gemma":0.00007959033,"teacher_disagreement_score":0.98510647,"about_ca_system_score_codex":0.00003283129,"about_ca_system_score_gemma":0.00027324999,"threshold_uncertainty_score":0.7887423},"labels":[],"label_agreement":null},{"id":"W2769848324","doi":"10.2147/ceor.s144695","title":"Do reimbursement recommendation processes used by government drug plans in Canada adhere to good governance principles?","year":2017,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Fraser Institute; Institute of Health Services and Policy Research; Oakville-Trafalgar Memorial Hospital; Canadian Institute for Health Information","funders":"","keywords":"Accountability; Transparency (behavior); Health care; Corporate governance; Public administration; Reimbursement; Agency (philosophy); Government (linguistics); Political science; Public relations; Medicine; Business; Law; Sociology; Finance; Social science","score_opus":0.19176607204055293,"score_gpt":0.42345594978000467,"score_spread":0.23168987773945174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769848324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9315864,0.00038145212,0.000010361967,0.03173288,0.0005177902,0.00061499554,0.002621455,0.0000072345224,0.032527443],"genre_scores_gemma":[0.99126273,0.003256435,0.00008109831,0.0019719682,0.00009627382,0.00011823914,0.000025054884,0.000038337213,0.0031498661],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99711233,0.00003950118,0.001171717,0.00082677015,0.00009805325,0.0007516413],"domain_scores_gemma":[0.9976932,0.0005517956,0.0005521559,0.00075267284,0.000037287937,0.0004129353],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023883202,0.00024163621,0.000663621,0.000078997415,0.00038540224,0.0005314212,0.00086374726,0.0000898812,0.00050243695],"category_scores_gemma":[0.00083102984,0.0002762173,0.000065345615,0.00007865553,0.0000911047,0.00035122133,0.0006022791,0.00048617358,0.00020982923],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056157056,0.00010052836,0.95939255,0.00007020464,0.000052031817,0.0000031760496,0.00027720383,0.000058575686,0.0000019649642,0.02167354,0.009020811,0.009293276],"study_design_scores_gemma":[0.0017329967,0.00006754927,0.37355253,0.00003593405,0.00000299883,7.513724e-7,0.00030747996,0.0018446338,0.000100076555,0.0034863073,0.6184352,0.00043353174],"about_ca_topic_score_codex":0.2891398,"about_ca_topic_score_gemma":0.74102104,"teacher_disagreement_score":0.6094144,"about_ca_system_score_codex":0.0019083434,"about_ca_system_score_gemma":0.0005231879,"threshold_uncertainty_score":0.999969},"labels":[],"label_agreement":null},{"id":"W2789439243","doi":"10.2147/ceor.s154323","title":"Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada","year":2018,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; McMaster University; Hôpital du Saint-Sacrement; Programs for Assessment of Technology in Health Research Institute; St. Joseph’s Healthcare Hamilton; University of Calgary; Impact","funders":"","keywords":"Medicine; Idiopathic pulmonary fibrosis; Pulmonary fibrosis; Intensive care medicine; Fibrosis; Pathology; Internal medicine; Lung","score_opus":0.04095241265247752,"score_gpt":0.3918457891416383,"score_spread":0.3508933764891608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789439243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932141,0.0010308378,0.0000010487287,0.0028442177,0.0003632581,0.00032181517,0.00006044715,0.0000068895124,0.0021574153],"genre_scores_gemma":[0.9957096,0.0018909285,0.000060374176,0.0002607731,0.00055535906,0.000012480375,0.000010308601,0.000024034898,0.0014761249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977478,0.00017274673,0.0010136887,0.00051243755,0.0001447909,0.00040858422],"domain_scores_gemma":[0.99844784,0.00057249237,0.00012160332,0.00039154073,0.00011669651,0.00034983954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017074029,0.00016349708,0.00077254896,0.00020219605,0.000096329095,0.000037166454,0.00016097094,0.00018476421,0.000112377376],"category_scores_gemma":[0.00024935266,0.00014911385,0.0001291726,0.00007054257,0.0009703254,0.000108915934,0.0002838309,0.000454138,0.000018307857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019371357,0.00009557378,0.9681812,0.0002528493,0.000070179245,0.000057394347,0.00013091945,0.0000016396432,0.000087057364,0.00088532834,0.0007643322,0.027536368],"study_design_scores_gemma":[0.0014583749,0.0013956155,0.9805227,0.0003139341,0.00003720028,0.000019705507,0.0007957226,0.005251209,0.000052640822,0.00050442206,0.00944037,0.00020811507],"about_ca_topic_score_codex":0.60850203,"about_ca_topic_score_gemma":0.5399728,"teacher_disagreement_score":0.06852926,"about_ca_system_score_codex":0.00019946595,"about_ca_system_score_gemma":0.0014709688,"threshold_uncertainty_score":0.60806865},"labels":[],"label_agreement":null},{"id":"W2790036407","doi":"10.2147/ceor.s150900","title":"Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany – a real-world evidence analysis","year":2018,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Vifor Pharma","keywords":"Medicine; Intravenous iron; Iron deficiency; Iron-deficiency anemia; Anemia; Propensity score matching; Inflammatory bowel disease; Internal medicine; Pediatrics; Disease","score_opus":0.05395523311786152,"score_gpt":0.3973452044950837,"score_spread":0.34338997137722216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790036407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788207,0.0007685798,0.000002909285,0.0003314119,0.000037604063,0.0006956079,0.000009410282,0.000011058871,0.0002613219],"genre_scores_gemma":[0.9945685,0.004714942,0.0002278168,0.00017408839,0.000033100296,0.000027374894,0.000014886086,0.000025819063,0.00021342059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980409,0.00015220659,0.00044055918,0.0006121539,0.00026255974,0.00049161754],"domain_scores_gemma":[0.9986399,0.0003557803,0.00010488212,0.00044436686,0.0001139559,0.00034110388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011396939,0.0002203106,0.0005450003,0.00079511,0.0001303173,0.00008930411,0.00011832402,0.00008268292,0.00003895933],"category_scores_gemma":[0.0001640483,0.00015833767,0.000037227783,0.0004009185,0.00084084726,0.00022503259,0.000113616436,0.00037281623,0.000006206685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008755344,0.00019049723,0.98177135,0.00013352188,0.000028597671,0.0000080736845,0.00084872113,0.000011882783,0.000003460932,0.00009493394,0.000009409954,0.0081442045],"study_design_scores_gemma":[0.009306871,0.0010348384,0.98872536,0.0000645241,0.0001180451,4.448424e-7,0.00022910471,0.0001867397,0.0000012393164,0.000041685213,0.00009428708,0.00019688412],"about_ca_topic_score_codex":0.00074697495,"about_ca_topic_score_gemma":0.011862801,"teacher_disagreement_score":0.011115827,"about_ca_system_score_codex":0.000089371184,"about_ca_system_score_gemma":0.00025971458,"threshold_uncertainty_score":0.66197217},"labels":[],"label_agreement":null},{"id":"W2794182884","doi":"10.2147/ceor.s144208","title":"Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes","year":2018,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Bristol-Myers Squibb (Canada); Augmentium Pharma Consulting (Canada)","funders":"Bristol-Myers Squibb","keywords":"Medicine; Clinical trial; Quality-adjusted life year; Markov model; Time horizon; Quality of life (healthcare); Disease; Economic model; Matching (statistics); Intensive care medicine; Oncology; Markov chain; Internal medicine; Machine learning; Computer science; Cost effectiveness; Risk analysis (engineering); Pathology; Mathematics","score_opus":0.5255296714953919,"score_gpt":0.6089148835745423,"score_spread":0.0833852120791504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794182884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9101382,0.000539642,0.008081389,0.07143498,0.002472658,0.0016430641,0.00048444822,0.000044600463,0.0051610456],"genre_scores_gemma":[0.9653557,0.0009264378,0.005472105,0.025482463,0.0006595259,0.00021056722,0.000018089644,0.00010284999,0.0017722716],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98745334,0.0011034963,0.008616927,0.00145621,0.0002070082,0.001163012],"domain_scores_gemma":[0.98233837,0.0128411185,0.0019958038,0.001869481,0.00036812536,0.0005871144],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.050700042,0.0004974437,0.0032817896,0.00075814384,0.00066692807,0.00024590414,0.0016624288,0.0009427436,0.00035082607],"category_scores_gemma":[0.009018509,0.00043939374,0.0006861916,0.00018508304,0.0010934125,0.0005015369,0.00097492815,0.00170465,0.0022282873],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017392387,0.00027026705,0.70643485,0.00008804704,0.0010906208,0.0000012469103,0.011279493,0.02686033,4.398015e-7,0.24156438,0.009154717,0.0030817112],"study_design_scores_gemma":[0.0023693556,0.00043590475,0.05181053,0.00005081471,0.00003070787,0.000002720142,0.0070680073,0.81867826,0.0000026588564,0.10541475,0.013420534,0.00071577955],"about_ca_topic_score_codex":0.0031576508,"about_ca_topic_score_gemma":0.0012126798,"teacher_disagreement_score":0.7918179,"about_ca_system_score_codex":0.0011727727,"about_ca_system_score_gemma":0.00089979084,"threshold_uncertainty_score":0.9998058},"labels":[],"label_agreement":null},{"id":"W2795793258","doi":"10.2147/ceor.s155038","title":"Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada","year":2018,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Impact; Programs for Assessment of Technology in Health Research Institute; University of Saskatchewan; Regina General Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Uterine fibroids; Radiofrequency ablation; Uterine myomectomy; Ablation; Laparoscopy; Clinical trial; General surgery; Obstetrics; Surgery; Myoma; Uterus; Internal medicine","score_opus":0.07032429785884224,"score_gpt":0.45542597000724355,"score_spread":0.3851016721484013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795793258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603224,0.0010126882,0.0000064369488,0.0006623415,0.00013338302,0.002000456,0.00003395428,0.000010384926,0.00010809873],"genre_scores_gemma":[0.99290055,0.005554242,0.0011515869,0.00013939691,0.000044573862,0.00005766677,0.000023146491,0.000019074783,0.00010974448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975501,0.00026763178,0.00134763,0.0003945454,0.00016274568,0.0002773501],"domain_scores_gemma":[0.99802923,0.0010192093,0.00032237775,0.00028827126,0.00015094643,0.00018998694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017096289,0.000184455,0.0016191062,0.0002758001,0.0000807766,0.000031806812,0.00006904985,0.00011508916,0.000011109326],"category_scores_gemma":[0.00049613573,0.00014536062,0.00006770492,0.00009637414,0.00045561267,0.00010600243,0.00016250488,0.0001968898,1.820985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01582578,0.00007362123,0.94941837,0.0006542047,0.00014891347,0.0000021976352,0.00051537703,1.0599429e-7,0.00001533185,0.00019991495,0.000005817345,0.03314038],"study_design_scores_gemma":[0.19494735,0.0018099538,0.8017351,0.00018380603,0.000042282663,0.0000047089716,0.00020789757,0.0006150136,0.00013540535,0.00015712871,0.00007090168,0.00009046842],"about_ca_topic_score_codex":0.11753749,"about_ca_topic_score_gemma":0.058391906,"teacher_disagreement_score":0.17912157,"about_ca_system_score_codex":0.00019323098,"about_ca_system_score_gemma":0.0008397259,"threshold_uncertainty_score":0.95879},"labels":[],"label_agreement":null},{"id":"W2896465630","doi":"10.2147/ceor.s167500","title":"Economic analysis of pharmacist-administered influenza vaccines in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Neighbourhood Pharmacy Association of Canada; University of Waterloo; McMaster University; Impact; Programs for Assessment of Technology in Health Research Institute","funders":"University of Waterloo","keywords":"Vaccination; Medicine; Influenza vaccine; Productivity; Pharmacist; Health care; Influenza season; Immunization; Indirect costs; Population; Environmental health; Family medicine; Pharmacy; Virology; Immunology; Business; Economic growth","score_opus":0.2505315414352499,"score_gpt":0.5190118989641723,"score_spread":0.2684803575289224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896465630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238586,0.00020129334,4.13387e-7,0.00060793565,0.00017603268,0.0004075164,0.00006736633,0.000006433616,0.0061471188],"genre_scores_gemma":[0.9964799,0.0002846118,0.00011283605,0.001031278,0.000072950956,0.000030920404,0.000014038551,0.00001916726,0.001954281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752235,0.00011444407,0.0010093926,0.00048894924,0.00025223146,0.000612625],"domain_scores_gemma":[0.9975918,0.0011547152,0.00014148232,0.00054490485,0.00029856962,0.00026851267],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018824093,0.00018615376,0.0010893072,0.0010670071,0.0001324898,0.000040874547,0.00025316252,0.00009735533,0.0011755959],"category_scores_gemma":[0.0004850831,0.00016474315,0.00016861114,0.00035420066,0.00043497016,0.00009492114,0.0003762062,0.00054662395,0.0000405072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070249493,0.000062210886,0.99365,0.00004000557,0.0012536027,0.000015655107,0.00046089798,0.000028352655,0.000030279156,0.00013893208,0.0010290404,0.0025885077],"study_design_scores_gemma":[0.0027967864,0.00027700583,0.9563251,0.000016790813,0.00014561224,0.0000016843427,0.00031554836,0.0019822172,0.00022120237,0.00006703584,0.03771411,0.00013690464],"about_ca_topic_score_codex":0.89539135,"about_ca_topic_score_gemma":0.9951757,"teacher_disagreement_score":0.09978437,"about_ca_system_score_codex":0.0011589087,"about_ca_system_score_gemma":0.0029818309,"threshold_uncertainty_score":0.99973744},"labels":[],"label_agreement":null},{"id":"W2903168985","doi":"10.2147/ceor.s178825","title":"A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions","year":2018,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Impact; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"EconLit; Formulary; CINAHL; Medicine; Grey literature; MEDLINE; Health care; Population; Family medicine; Political science; Environmental health; Nursing; Psychological intervention","score_opus":0.9495857588377236,"score_gpt":0.7667037290534521,"score_spread":0.18288202978427148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903168985","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009392831,0.9535463,0.00116981,0.03908045,0.00023142908,0.002187961,0.0032903275,0.000015087411,0.00038474347],"genre_scores_gemma":[0.000016516156,0.97890997,0.013777885,0.0042617987,0.00057465077,0.00027883225,0.000507992,0.000053842974,0.0016184889],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98656625,0.0016979385,0.009582249,0.0012767406,0.00025160055,0.00062520575],"domain_scores_gemma":[0.9614201,0.033158388,0.0031225663,0.0005812596,0.0010067492,0.0007109322],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.0994961,0.00047410335,0.0067335805,0.0014811062,0.00026879983,0.00012689146,0.0005997155,0.00047527277,0.0014935295],"category_scores_gemma":[0.04407097,0.0004225666,0.0018280953,0.00059709325,0.00041573463,0.00022592722,0.00021996345,0.00059941626,0.00011015257],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006546413,0.00028216795,0.0048482274,0.12752913,0.007748202,8.461242e-7,0.00030940934,0.000014171281,1.9928608e-8,0.25941288,0.47488087,0.12490858],"study_design_scores_gemma":[0.0006384404,0.000087557564,0.00078635017,0.0026618193,0.0004243393,0.0000059083595,0.00004027364,0.0017784408,4.0932708e-8,0.018482586,0.97469544,0.00039881023],"about_ca_topic_score_codex":0.00009538962,"about_ca_topic_score_gemma":0.000039472103,"teacher_disagreement_score":0.49981457,"about_ca_system_score_codex":0.00050824776,"about_ca_system_score_gemma":0.0018920754,"threshold_uncertainty_score":0.9998226},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2942923076","doi":"10.2147/ceor.s195597","title":"<p>Electronic referral systems in health care: a scoping review</p>","year":2019,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Healthcare Systems and Technology","field":"Business, Management and Accounting","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute; Impact; McMaster University","funders":"","keywords":"Referral; Workflow; Medicine; Psychological intervention; Economic evaluation; Cost effectiveness; Healthcare system; Health care; Quality (philosophy); Cost–benefit analysis; Electronic database; Family medicine; Operations management; Medical emergency; Nursing; Computer science; Risk analysis (engineering); Database; Engineering; Pathology","score_opus":0.08609600033652381,"score_gpt":0.427272705291,"score_spread":0.34117670495447616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942923076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86129344,0.104475595,0.0000047194094,0.017926576,0.0014546679,0.0041960115,0.000006962089,0.0001235351,0.010518472],"genre_scores_gemma":[0.97125596,0.023568312,0.00001821738,0.00342622,0.00041315157,0.00017360445,0.000030066056,0.000057429836,0.0010570274],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961144,0.00015813636,0.0014391897,0.0007548662,0.0002571138,0.0012763061],"domain_scores_gemma":[0.998305,0.00032066612,0.0004058069,0.0007260837,0.00017982365,0.00006257706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063417414,0.00024758623,0.0011417513,0.00073264056,0.00022170988,0.00027760144,0.000477994,0.0002515508,0.000093891555],"category_scores_gemma":[0.00034864177,0.00022648174,0.00012241883,0.00047160176,0.00009523534,0.00041597287,0.0004624591,0.0007925059,0.00073630956],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007859071,0.00011687607,0.2875485,0.0688231,0.00008297776,0.000019393394,0.0001832729,0.000026555135,0.000024292063,0.5261601,0.0071353507,0.109800965],"study_design_scores_gemma":[0.0022156434,0.000218773,0.027426694,0.014844972,0.000008949183,0.000009427328,0.00051769125,0.0019559523,7.5355655e-7,0.001365888,0.95085895,0.000576316],"about_ca_topic_score_codex":0.0033007548,"about_ca_topic_score_gemma":0.009659191,"teacher_disagreement_score":0.9437236,"about_ca_system_score_codex":0.0004511072,"about_ca_system_score_gemma":0.00062732963,"threshold_uncertainty_score":0.94640154},"labels":[],"label_agreement":null},{"id":"W2965199654","doi":"10.2147/ceor.s208107","title":"<p>A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic stenosis patients</p>","year":2019,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Impact","funders":"","keywords":"Medicine; Stenosis; Aortic valve replacement; Aortic valve; Cardiology; Internal medicine; Surgery; Emergency medicine","score_opus":0.03145730732039322,"score_gpt":0.3730813773028239,"score_spread":0.3416240699824307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965199654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755913,0.00014888316,0.0000019060883,0.000047792866,0.00010307167,0.0012969504,0.0007498174,0.00000621298,0.00008623447],"genre_scores_gemma":[0.998327,0.000937915,0.000010365656,0.000056726272,0.000010836146,0.00008995624,0.0005096368,0.000027563898,0.000030010946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980091,0.00025415386,0.00057250104,0.00049422256,0.00021381842,0.00045620246],"domain_scores_gemma":[0.9974056,0.0014570575,0.00016219895,0.00035910372,0.0001978389,0.00041818802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008893457,0.0002053927,0.0011498638,0.0010514483,0.00007177156,0.000051962834,0.00007437368,0.000104590894,0.000072163304],"category_scores_gemma":[0.00009861641,0.00016481127,0.0007220154,0.0003744015,0.0001419877,0.000108989436,0.00004390832,0.00019056106,0.000013771996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007497132,0.00021721932,0.97259617,0.0001464397,0.003723621,0.0000031239147,0.0003182973,0.00007321689,0.0000047672183,0.000019253908,0.00000724673,0.022140924],"study_design_scores_gemma":[0.0044487347,0.00036136067,0.99138707,0.000086530825,0.0020154316,7.236186e-7,0.0001274673,0.0013396171,0.0000068084846,0.000035598212,0.000025255571,0.00016540868],"about_ca_topic_score_codex":0.013802337,"about_ca_topic_score_gemma":0.019546833,"teacher_disagreement_score":0.021975515,"about_ca_system_score_codex":0.00029068993,"about_ca_system_score_gemma":0.000266236,"threshold_uncertainty_score":0.9983439},"labels":[],"label_agreement":null},{"id":"W2992911505","doi":"10.2147/ceor.s224277","title":"<p>Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications</p>","year":2019,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Assurex Health","keywords":"Formulary; Medicine; Medical prescription; Pharmacogenomics; Pharmacy; Antipsychotic; Psychiatry; Test (biology); Family medicine; Schizophrenia (object-oriented programming); Pharmacology","score_opus":0.112147836875957,"score_gpt":0.483614907670712,"score_spread":0.37146707079475505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992911505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733931,0.0028284604,0.0000367126,0.0066676955,0.005148543,0.002705236,0.0006228206,0.000054086187,0.008543376],"genre_scores_gemma":[0.98827934,0.0046828757,0.00023955363,0.0030665416,0.00066686404,0.00045756355,0.00027081405,0.00008244084,0.0022540267],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99615365,0.00059374934,0.00093323854,0.0008221555,0.0003270827,0.0011701332],"domain_scores_gemma":[0.9944262,0.0031407191,0.0003886779,0.00046614313,0.00044531134,0.0011329401],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0069381767,0.0003512421,0.0006754305,0.0005970791,0.0007539083,0.00011266336,0.00082232105,0.0005386015,0.0011049737],"category_scores_gemma":[0.0005124444,0.00033115476,0.00017360618,0.00036783578,0.00049204816,0.00016587865,0.00016000369,0.0010644243,0.0003547358],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019779142,0.0015937582,0.67263544,0.00030546702,0.0030986618,0.00001846068,0.0014227161,0.00039367413,0.019606408,0.07855279,0.08382738,0.13656735],"study_design_scores_gemma":[0.012803934,0.00028220608,0.071601324,0.000022019867,0.00030663924,0.000005889744,0.000057347548,0.0141758835,0.00081878906,0.0036470625,0.89571196,0.00056696485],"about_ca_topic_score_codex":0.0001464043,"about_ca_topic_score_gemma":0.0012355829,"teacher_disagreement_score":0.8118846,"about_ca_system_score_codex":0.00037041976,"about_ca_system_score_gemma":0.0013406442,"threshold_uncertainty_score":0.99991405},"labels":[],"label_agreement":null},{"id":"W2995955619","doi":"10.2147/ceor.s156558","title":"<p>North American cost analysis of brand name versus generic drugs for the treatment of glaucoma</p>","year":2019,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo; Western University","funders":"","keywords":"Medicine; Glaucoma; Formulary; Medical prescription; Pharmacy; Brand names; Generic drug; Family medicine; Optometry; Drug; Pharmacology; Ophthalmology; Advertising; Business","score_opus":0.053594725341810145,"score_gpt":0.39482335125487306,"score_spread":0.3412286259130629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995955619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506176,0.0013291865,0.00001277406,0.0012518973,0.00019077216,0.0012512901,0.00011922748,0.0000070373685,0.00077607465],"genre_scores_gemma":[0.98778516,0.010078386,0.00014780404,0.00009448194,0.000045541277,0.00006784964,0.000079581725,0.000025510806,0.001675696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824536,0.00008747221,0.0006433371,0.00038865846,0.00022651283,0.0004086413],"domain_scores_gemma":[0.99548,0.0032402175,0.000254368,0.00064832997,0.00020849718,0.00016858184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006670951,0.00018618406,0.0011232445,0.00039332733,0.00010498352,0.00002486321,0.0002144542,0.00006907289,0.00009980827],"category_scores_gemma":[0.00012692864,0.00011691028,0.00061161845,0.00051643566,0.0005934366,0.000032343414,0.00006683105,0.00012482582,0.000017147695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020264229,0.00033852868,0.92393786,0.00006713098,0.0026832204,0.0000011055865,0.0005306441,0.000016407397,0.00010304602,0.0003119643,0.0001492991,0.069834344],"study_design_scores_gemma":[0.005486817,0.0027621356,0.9387627,0.0000073603783,0.0009850819,5.975564e-7,0.0006676137,0.008937911,0.000058901733,0.000015275744,0.0422008,0.00011477646],"about_ca_topic_score_codex":0.00020965736,"about_ca_topic_score_gemma":0.001021045,"teacher_disagreement_score":0.06971957,"about_ca_system_score_codex":0.00010036789,"about_ca_system_score_gemma":0.0001605394,"threshold_uncertainty_score":0.4767463},"labels":[],"label_agreement":null},{"id":"W3010771737","doi":"10.2147/ceor.s234298","title":"<p>Stated Preferences for Attributes of a <em>CYP2C19</em> Pharmacogenetic Test Among the General Population Presented with a Hypothetical Acute Coronary Syndrome Scenario</p>","year":2020,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Eli Lilly (Canada); University of Ottawa; University of Toronto","funders":"","keywords":"Medicine; Acute coronary syndrome; Turnaround time; Test (biology); Point of care; CYP2C19; Pharmacogenetics; Willingness to pay; Population; Preference; Family medicine; Emergency medicine; Internal medicine; Statistics; Computer science; Nursing; Environmental health","score_opus":0.15448870244248053,"score_gpt":0.3364111831194406,"score_spread":0.1819224806769601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010771737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923788,0.0010993228,0.00023567869,0.002448681,0.00019888094,0.0017754318,0.0013829097,0.000035740548,0.00044456273],"genre_scores_gemma":[0.99457246,0.0022694,0.0007736027,0.00035341547,0.00011457654,0.00026246335,0.00040911068,0.00008599183,0.0011589704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960512,0.00014761086,0.0017168619,0.001100776,0.0001774708,0.00080606865],"domain_scores_gemma":[0.99682796,0.001415793,0.0007139496,0.0005605507,0.00010304203,0.00037868234],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020938555,0.0004263525,0.0011169025,0.00026940755,0.00040866167,0.00026224597,0.00068809337,0.00026912193,0.00043312876],"category_scores_gemma":[0.00042594929,0.00036967796,0.00028907755,0.00025995812,0.0005827512,0.0004116896,0.0004038517,0.00041886023,0.00015795781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035331523,0.00027849223,0.98859066,0.00010909245,0.0005440072,0.000008274011,0.00053933315,0.0014190678,0.00037704446,0.0039978637,0.0011274104,0.0026554386],"study_design_scores_gemma":[0.002998973,0.0010412426,0.90091145,0.000028587961,0.00008705287,0.00001608915,0.000117936266,0.08790139,0.000110692796,0.0033929907,0.0029488606,0.00044476226],"about_ca_topic_score_codex":0.00005380983,"about_ca_topic_score_gemma":0.00024554192,"teacher_disagreement_score":0.08767924,"about_ca_system_score_codex":0.00022704822,"about_ca_system_score_gemma":0.00009783144,"threshold_uncertainty_score":0.99987555},"labels":[],"label_agreement":null},{"id":"W3023368852","doi":"10.2147/ceor.s238725","title":"<p>Economic Evaluation of Single versus Combination Immuno-Oncology Therapies: Application of a Novel Modelling Approach in Metastatic Melanoma</p>","year":2020,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"Bristol-Myers Squibb","keywords":"Medicine; Ipilimumab; Oncology; Progression-free survival; Regimen; Internal medicine; Clinical trial; Nivolumab; Metastatic melanoma; Cancer; Overall survival; Immunotherapy","score_opus":0.22576595778938763,"score_gpt":0.429442170650173,"score_spread":0.20367621286078536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023368852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852804,0.00041276787,0.007037449,0.0013613743,0.00014002682,0.0014126179,0.000014256716,0.000013145874,0.004327984],"genre_scores_gemma":[0.9968981,0.0003896675,0.0023703945,0.000084009414,0.000034602814,0.000106861655,0.00004660569,0.000021887694,0.00004785085],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980888,0.00020009867,0.0008585625,0.0003809777,0.00025864714,0.00021294532],"domain_scores_gemma":[0.99839455,0.00069322775,0.00030293115,0.00029100408,0.00022196154,0.00009630752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003178781,0.00012974447,0.0005949688,0.00034890548,0.000049644685,0.000020950481,0.000140202,0.00010281456,0.00004602185],"category_scores_gemma":[0.00018990468,0.00012876105,0.00010756932,0.00015909314,0.00015257347,0.00008061744,0.00010511765,0.00018486055,0.0000102371305],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0122511545,0.007544142,0.01741164,0.0018450072,0.0025204243,0.000007814337,0.014445253,0.13084151,0.085686296,0.06161408,0.0003219319,0.6655108],"study_design_scores_gemma":[0.011100112,0.0014543246,0.0030518717,0.000015827607,0.0001265106,0.0000047079648,0.0013693039,0.97862166,0.0005074002,0.0004707435,0.003155918,0.000121638244],"about_ca_topic_score_codex":0.00006425736,"about_ca_topic_score_gemma":0.000094547904,"teacher_disagreement_score":0.84778017,"about_ca_system_score_codex":0.00042213625,"about_ca_system_score_gemma":0.00023359715,"threshold_uncertainty_score":0.52507234},"labels":[],"label_agreement":null},{"id":"W3046450200","doi":"10.2147/ceor.s252244","title":"<p>Socioeconomic Inequality in Self-Medication in Iran: Cross-Sectional Analyses at the National and Subnational Levels</p>","year":2020,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Kermanshah University of Medical Sciences","keywords":"Socioeconomic status; Inequality; Cross-sectional study; Confidence interval; Geography; Proxy (statistics); Medicine; Socioeconomics; Demography; Environmental health; Population; Economics; Mathematics; Statistics; Sociology","score_opus":0.20165184383066015,"score_gpt":0.4650078080743688,"score_spread":0.26335596424370866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046450200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99008894,0.0017803123,0.0000070339606,0.0065937657,0.00017261108,0.00023599855,0.00012698266,0.000013374718,0.0009809743],"genre_scores_gemma":[0.9965415,0.0010138497,0.000036881225,0.001038035,0.000082244005,0.000015342297,0.000099796154,0.000011618697,0.0011607319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793524,0.0003629936,0.0007505486,0.00052237994,0.000094388095,0.00033445779],"domain_scores_gemma":[0.99750555,0.0020496836,0.00015261114,0.00013829155,0.00009724902,0.00005660285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029146913,0.00014511723,0.00034147376,0.00018534657,0.00033130602,0.00007117413,0.00024551162,0.00028983367,0.00073069666],"category_scores_gemma":[0.0005306433,0.000114696384,0.00008042427,0.00011738957,0.00068134634,0.00014221188,0.0002620827,0.00051626476,0.0003276191],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013742759,0.0000838817,0.9911651,0.000032326687,0.00010383212,0.0000012664422,0.00047450105,0.000050405128,0.0024475984,0.0040897406,0.0010118396,0.00040205655],"study_design_scores_gemma":[0.0017717375,0.00004719231,0.9857949,0.0000062855584,0.0000046736973,0.000004871658,0.000090556954,0.0006703178,0.00017072975,0.0008556819,0.010457552,0.00012548229],"about_ca_topic_score_codex":0.00004110535,"about_ca_topic_score_gemma":0.001002278,"teacher_disagreement_score":0.009445712,"about_ca_system_score_codex":0.00024897527,"about_ca_system_score_gemma":0.0002142034,"threshold_uncertainty_score":0.8000616},"labels":[],"label_agreement":null},{"id":"W3081149819","doi":"10.2147/ceor.s264589","title":"<p>Can Standard Health Technology Assessment Approaches Help Guide the Price of Orphan Drugs in Canada? A Review of Submissions to the Canadian Agency for Drugs and Technologies in Health Common Drug Review</p>","year":2020,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Medicine; Reimbursement; Health technology; Per capita; Agency (philosophy); Excellence; Family medicine; Health care; Environmental health; Population; Economic growth","score_opus":0.45923800031079876,"score_gpt":0.5528400443968733,"score_spread":0.09360204408607453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081149819","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015671721,0.63914365,0.000006344333,0.35140023,0.00013858697,0.0070846016,0.0018218562,0.0000097130805,0.00023831263],"genre_scores_gemma":[0.0009164104,0.98659986,0.00096336997,0.009450909,0.000040602,0.0016875168,0.000109526794,0.000069220616,0.00016259323],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98359346,0.0019732243,0.011678046,0.0012400256,0.0002700749,0.0012451551],"domain_scores_gemma":[0.98666793,0.0058508567,0.0051585194,0.0016098549,0.00017709391,0.00053575396],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.07645579,0.0005205441,0.007391348,0.0014234559,0.00049608055,0.00006980996,0.0017175915,0.0003090495,0.000028863795],"category_scores_gemma":[0.008636985,0.0004177672,0.00032972908,0.0013178068,0.00040401923,0.00009502461,0.0006432586,0.0013209411,0.000009141134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000009330551,0.00006414105,0.0074829906,0.24099132,0.0001954955,0.0000013179459,0.0012721157,0.0000047507697,3.949411e-9,0.06854512,0.073441066,0.60799235],"study_design_scores_gemma":[0.00036806823,0.00014764695,0.0008505237,0.034970727,0.000019039802,0.0000034589837,0.0022327118,0.00013892018,3.8605588e-8,0.0017228232,0.9592304,0.00031562705],"about_ca_topic_score_codex":0.49814114,"about_ca_topic_score_gemma":0.95257586,"teacher_disagreement_score":0.88578933,"about_ca_system_score_codex":0.007331505,"about_ca_system_score_gemma":0.027368898,"threshold_uncertainty_score":0.99982744},"labels":[],"label_agreement":null},{"id":"W3127435253","doi":"10.2147/ceor.s282253","title":"Short and Mid-Term Economic Impact of Pulmonary Artery Catheter Use in Adult Cardiac Surgery: A Hospital and Integrated Health System Perspective","year":2021,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Hemodynamic Monitoring and Therapy","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Edwards Lifesciences","keywords":"Medicine; Pulmonary artery catheter; Cardiac surgery; Catheter; Emergency medicine; Intensive care medicine; Surgery; Internal medicine; Cardiac output; Hemodynamics","score_opus":0.05843146478753089,"score_gpt":0.4216618694035618,"score_spread":0.36323040461603096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127435253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713844,0.0013058452,0.000001265128,0.0007233742,0.0002293098,0.0003689007,0.0001524065,0.000011474321,0.00006897388],"genre_scores_gemma":[0.99365586,0.005989283,0.00003832884,0.0000401988,0.00007910515,0.00001988289,0.000033186298,0.000027753584,0.0001163998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982401,0.00024657234,0.00056964793,0.0004904927,0.000080183054,0.00037298969],"domain_scores_gemma":[0.99804616,0.0010990233,0.000077278295,0.0003288746,0.00016443648,0.00028420883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013483742,0.00017437708,0.0010169202,0.00029354208,0.00006461483,0.00007842877,0.00004699456,0.00012762306,0.0000066608536],"category_scores_gemma":[0.00015014513,0.000145826,0.00020429278,0.00007427291,0.00019892753,0.000115850635,0.00008879976,0.000401558,0.0000021394114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001631242,0.00010405864,0.9815737,0.00014545197,0.00026129448,0.00005682301,0.0007494312,0.0000013346728,0.00004315863,0.00013323849,0.00003312349,0.016735263],"study_design_scores_gemma":[0.00059202325,0.00030154554,0.9928792,0.00022972448,0.000014165247,0.00005629054,0.003283074,0.0023859197,0.000048986556,0.00003837506,0.000036667654,0.00013400814],"about_ca_topic_score_codex":0.0022871203,"about_ca_topic_score_gemma":0.00012696494,"teacher_disagreement_score":0.016601255,"about_ca_system_score_codex":0.00085690455,"about_ca_system_score_gemma":0.0007496208,"threshold_uncertainty_score":0.5946612},"labels":[],"label_agreement":null},{"id":"W3159645717","doi":"10.2147/ceor.s304600","title":"Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis","year":2021,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Rheumatoid arthritis; Quality of life (healthcare); Quality-adjusted life year; Cost effectiveness; Internal medicine; Physical therapy; Pediatrics","score_opus":0.08182627797173322,"score_gpt":0.43082203205475506,"score_spread":0.34899575408302186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159645717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973853,0.023867322,0.000053359647,0.0001341331,0.0002710344,0.0013670634,0.0001956818,0.000004635089,0.00025376093],"genre_scores_gemma":[0.7992299,0.20040259,0.00011608106,0.0000023912905,0.000018980963,0.00014728037,0.000024903393,0.000013729116,0.0000440983],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985438,0.0002498673,0.00051843835,0.00024247849,0.00021187043,0.00023351815],"domain_scores_gemma":[0.99355125,0.0048947525,0.00015040641,0.0003647797,0.00094635005,0.00009242862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043561152,0.00010568933,0.0007438538,0.00011712404,0.00014814602,0.000019687077,0.00007367569,0.000079890386,0.000022071168],"category_scores_gemma":[0.00054528104,0.00007730483,0.00024532722,0.000100446996,0.0005147256,0.000053084896,0.00004882638,0.00013124551,6.2698143e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037979126,0.00061831897,0.13303556,0.000744038,0.0014222403,0.000012548275,0.0034389356,0.000040863215,0.0028466743,0.0029290386,0.000028537808,0.8169041],"study_design_scores_gemma":[0.04966413,0.044595238,0.38987732,0.001221967,0.000042831132,0.000053085503,0.032175142,0.0004617571,0.46076554,0.0008737127,0.020008469,0.00026081584],"about_ca_topic_score_codex":0.00019148462,"about_ca_topic_score_gemma":0.00036181044,"teacher_disagreement_score":0.8166433,"about_ca_system_score_codex":0.00017076006,"about_ca_system_score_gemma":0.00057396287,"threshold_uncertainty_score":0.31523997},"labels":[],"label_agreement":null},{"id":"W3193000380","doi":"10.2147/ceor.s304395","title":"Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada","year":2021,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Diabetes Management and Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Dexcom","keywords":"Fingerstick; Medicine; Continuous glucose monitoring; Hypoglycemia; Glycemic; Type 1 diabetes; Life expectancy; Type 2 diabetes; Blood Glucose Self-Monitoring; Diabetes mellitus; Emergency medicine; Intensive care medicine; Endocrinology; Environmental health; Population","score_opus":0.07250680510475792,"score_gpt":0.39753152082730214,"score_spread":0.3250247157225442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193000380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672943,0.001235789,6.123373e-8,0.00014265669,0.0003851992,0.0012621336,0.00000891242,0.0000017830379,0.00023405788],"genre_scores_gemma":[0.9994042,0.00042252938,0.00001573336,0.0000060477564,0.000025690833,0.00005280871,0.000004439437,0.000015003591,0.000053549506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975049,0.0008139564,0.0004531695,0.0002449326,0.0006592818,0.0003237928],"domain_scores_gemma":[0.996507,0.002067916,0.00014506621,0.00049643347,0.0007208494,0.00006277165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047992133,0.00010720285,0.00051592756,0.00014138516,0.000046312933,0.000017787594,0.00026590278,0.000062016414,0.00001788287],"category_scores_gemma":[0.0011642656,0.00006709295,0.00006991249,0.00052322174,0.00015315958,0.00005155293,0.00035270862,0.00037753658,4.6735747e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000287307,0.00029016563,0.9848276,0.0004859103,0.00027454842,0.0000037326222,0.00009189152,0.00010672765,0.0007295868,0.000021532942,0.000002034504,0.012878979],"study_design_scores_gemma":[0.0058982363,0.0002206645,0.95316905,0.000373135,0.00014757806,2.3159433e-7,0.0004956458,0.0010935614,0.03850964,0.000025086458,0.000006091695,0.00006109775],"about_ca_topic_score_codex":0.01599175,"about_ca_topic_score_gemma":0.19463429,"teacher_disagreement_score":0.17864254,"about_ca_system_score_codex":0.00036836613,"about_ca_system_score_gemma":0.0020990127,"threshold_uncertainty_score":0.9905608},"labels":[],"label_agreement":null},{"id":"W3207707436","doi":"10.2147/ceor.s330118","title":"Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Multiple sclerosis; Pediatrics; Internal medicine; Immunology","score_opus":0.32486510438298205,"score_gpt":0.4743038505719606,"score_spread":0.14943874618897857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207707436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960728,0.0009746705,0.00012133039,0.00045191633,0.00014335333,0.0020420316,0.0000814115,0.0000049656137,0.00010747503],"genre_scores_gemma":[0.9810757,0.017467743,0.0003418691,0.000012263931,0.000039959894,0.00067896146,0.000020050828,0.000014842267,0.00034862297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984585,0.00027938912,0.000542204,0.00029508173,0.00016353514,0.00026130085],"domain_scores_gemma":[0.9897748,0.009165585,0.00009583617,0.0003934339,0.00049491785,0.00007540082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000835522,0.000101934085,0.0005523222,0.0001756856,0.00017014629,0.000021834945,0.00007660863,0.000076688324,0.000009494995],"category_scores_gemma":[0.0010715788,0.00007125712,0.00018862993,0.00019412076,0.0003787521,0.00004692864,0.000086899585,0.0001464332,0.0000011285067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092496315,0.00076181145,0.93051356,0.00022134512,0.00060597237,0.0000024700462,0.00051417307,0.00010843133,0.012500256,0.00013248036,0.000028894869,0.05368565],"study_design_scores_gemma":[0.0050568176,0.0013057011,0.9633376,0.00010344552,0.00006784475,0.000002661361,0.0009157469,0.0051295497,0.023506204,0.000050214894,0.00047049407,0.000053717216],"about_ca_topic_score_codex":0.0003708194,"about_ca_topic_score_gemma":0.00034587327,"teacher_disagreement_score":0.05363193,"about_ca_system_score_codex":0.00026414634,"about_ca_system_score_gemma":0.00026306653,"threshold_uncertainty_score":0.2905781},"labels":[],"label_agreement":null},{"id":"W3216182527","doi":"10.2147/ceor.s336915","title":"Cost-Effectiveness of Once-Daily, Single-Inhaler Indacaterol Acetate/ Glycopyrronium Bromide/ Mometasone Furoate in Patients with Uncontrolled Moderate-to-Severe Asthma in Canada","year":2021,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Novartis (Canada)","funders":"Novartis Pharma","keywords":"Medicine; Indacaterol; Mometasone furoate; Fluticasone propionate; Asthma; Salmeterol; Exacerbation; Inhaler; Cost effectiveness; Internal medicine; Dry-powder inhaler; Corticosteroid; Bronchodilator","score_opus":0.05274054645496132,"score_gpt":0.35609865220691533,"score_spread":0.303358105751954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216182527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974094,0.00021837142,0.0000061366045,0.00039620764,0.000112817244,0.0015083044,0.000100070174,0.00000555347,0.00024315048],"genre_scores_gemma":[0.9990266,0.00006845111,0.000075861804,0.00036867813,0.000020080752,0.0001139737,0.000055230143,0.00004090989,0.00023019181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970793,0.00054747117,0.0007701644,0.0006214299,0.00036334436,0.0006182945],"domain_scores_gemma":[0.9975263,0.0010997084,0.00012612456,0.00043668872,0.00040529316,0.00040591953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010593141,0.00025237797,0.0012053374,0.00037341114,0.00006558549,0.00004844908,0.00015868289,0.00012045396,0.000088535],"category_scores_gemma":[0.000398645,0.0002013052,0.00008898991,0.00039376828,0.0001410087,0.00012663542,0.00019943416,0.0005110329,0.000009870537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075450065,0.0005383711,0.97654927,0.00025480991,0.00010714682,0.0001595287,0.00009331815,0.001697951,0.00008858065,0.000011078742,0.000034659948,0.012920291],"study_design_scores_gemma":[0.020879433,0.00071269774,0.97530645,0.0002661568,0.00001751393,0.0000035417318,0.0004358369,0.00088967726,0.00082063413,0.000026663503,0.00043000554,0.0002114182],"about_ca_topic_score_codex":0.033121053,"about_ca_topic_score_gemma":0.27383885,"teacher_disagreement_score":0.24071778,"about_ca_system_score_codex":0.00083908765,"about_ca_system_score_gemma":0.003013326,"threshold_uncertainty_score":0.9733175},"labels":[],"label_agreement":null},{"id":"W4205403076","doi":"10.2147/ceor.s340385","title":"Issue with Evaluating Costs Over Time in a Context of Medical Guideline Changes: An Example in Myocardial Infarction Care Based on a Longitudinal Study from 1997 to 2018","year":2022,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec à Montréal; Université du Québec à Trois-Rivières; Centre hospitalier de l'Université Laval; Université du Québec à Rimouski; Institut universitaire de cardiologie et de pneumologie de Québec; Université Laval","funders":"","keywords":"Context (archaeology); Myocardial infarction; Longitudinal study; Guideline; Health care; Medical care","score_opus":0.1787159488843767,"score_gpt":0.49802267511247633,"score_spread":0.31930672622809964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205403076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98631454,0.00006279356,0.000010624179,0.01080878,0.0001531684,0.0022179391,0.00017855017,0.000013209761,0.00024039342],"genre_scores_gemma":[0.99197567,0.000034059438,0.00020130805,0.0067256154,0.00023497007,0.00043916865,0.00024956156,0.000043812564,0.00009585912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99504167,0.001126056,0.0008671881,0.0007927245,0.0016686353,0.0005037127],"domain_scores_gemma":[0.9967919,0.0017032656,0.00011314875,0.0006777091,0.00030410016,0.00040988],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008867342,0.00019834361,0.00085354375,0.0010919428,0.00015583127,0.000050111234,0.00033056096,0.00013164384,0.0015879545],"category_scores_gemma":[0.0008966827,0.00017771691,0.00007608322,0.00055528013,0.0001648854,0.00007454781,0.0005555251,0.0012108091,0.00003481495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050809067,0.000817655,0.9442246,0.00002165069,0.00014129019,0.000080206155,0.0031027335,0.00073143834,0.00003349507,0.000010201586,0.0032808962,0.04247495],"study_design_scores_gemma":[0.013966965,0.01284383,0.86702234,0.000082432955,0.00003092255,0.0000043408936,0.022817489,0.067966774,0.000011485091,0.000012799444,0.015009515,0.00023109911],"about_ca_topic_score_codex":0.0381195,"about_ca_topic_score_gemma":0.011145113,"teacher_disagreement_score":0.07720222,"about_ca_system_score_codex":0.0010062032,"about_ca_system_score_gemma":0.0008406298,"threshold_uncertainty_score":0.99932474},"labels":[],"label_agreement":null},{"id":"W4205946049","doi":"10.2147/ceor.s341896","title":"Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR)","year":2022,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Pfizer","keywords":"Bladder cancer; Systematic review; Discontinuation; Generalization; MEDLINE; Cancer survival; Patient data; Overall survival","score_opus":0.15233066222282354,"score_gpt":0.48595328997153875,"score_spread":0.3336226277487152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205946049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8078379,0.18200137,3.4060056e-7,0.0051501743,0.00042861933,0.0039037666,0.0003080023,0.000018097113,0.00035172573],"genre_scores_gemma":[0.50089014,0.4930914,0.000052537744,0.0007839909,0.000050548028,0.0014313114,0.000016000226,0.000032657947,0.0036514285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99618316,0.0006686183,0.0014058971,0.0007390774,0.00046766573,0.00053561054],"domain_scores_gemma":[0.99416983,0.003971741,0.00043598242,0.0009058208,0.0002967878,0.0002198114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021248297,0.00036476555,0.0023790214,0.000520517,0.00025742684,0.00004261401,0.0002961678,0.00008217588,0.000269056],"category_scores_gemma":[0.0009704503,0.00025469885,0.0003517848,0.00061231613,0.00019996792,0.0001540532,0.0003997906,0.0006532504,0.000019499766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025323828,0.0005902568,0.95358926,0.032827094,0.0019478021,0.0001497113,0.002744921,0.000032613247,0.000008277046,0.00014624161,0.0012217046,0.0064889085],"study_design_scores_gemma":[0.0073599447,0.0031959482,0.9450021,0.03816104,0.0012685849,0.000019052211,0.0029705775,0.00009827698,0.00007911291,0.00056288985,0.0008297462,0.00045274425],"about_ca_topic_score_codex":0.004396156,"about_ca_topic_score_gemma":0.0044732587,"teacher_disagreement_score":0.31109005,"about_ca_system_score_codex":0.0013164195,"about_ca_system_score_gemma":0.00077580765,"threshold_uncertainty_score":0.9999905},"labels":[],"label_agreement":null},{"id":"W4211057148","doi":"10.2147/ceor.s346736","title":"Sensor-Based Technology: Bringing Value to People with Diabetes and the Healthcare System in an Evolving World","year":2022,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Mobile Health and mHealth Applications","field":"Health Professions","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Abbott Diabetes Care","keywords":"Telemedicine; Healthcare system; Value (mathematics); Diabetes mellitus; Continuous glucose monitoring; Quality (philosophy); Diabetes treatment","score_opus":0.07887705250147578,"score_gpt":0.4857573155308227,"score_spread":0.4068802630293469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211057148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93476,0.00056234916,0.000019137979,0.059313625,0.0001563051,0.004643342,0.000041598327,0.00007243,0.0004312317],"genre_scores_gemma":[0.98160696,0.00007328269,0.00062647084,0.0057331477,0.00006884189,0.011524061,0.000012178074,0.000037702022,0.00031738364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960004,0.0013511375,0.00082244846,0.0005790269,0.00019988217,0.0010471113],"domain_scores_gemma":[0.99400043,0.0045477347,0.0001816339,0.0006529434,0.00016378079,0.00045344446],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.008542175,0.00014753679,0.00055612915,0.00086389756,0.0030585793,0.000043105163,0.0003308575,0.00009730011,0.00004280713],"category_scores_gemma":[0.00031997287,0.000111521535,0.000029231049,0.0008394179,0.00018431319,0.00006677351,0.00050389767,0.001864385,0.00001817149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001430489,0.000028344875,0.9602503,0.0004964465,0.0000058016967,0.0000011945202,0.0008585798,0.00019015993,9.982672e-7,0.031202199,0.00018285877,0.006640045],"study_design_scores_gemma":[0.0061372197,0.0004915193,0.8577594,0.0002956799,0.000011794442,0.000002145286,0.0454952,0.059528477,0.0000015137118,0.0012719083,0.028717177,0.00028796712],"about_ca_topic_score_codex":0.0012500642,"about_ca_topic_score_gemma":0.007008895,"teacher_disagreement_score":0.10249093,"about_ca_system_score_codex":0.00055401126,"about_ca_system_score_gemma":0.00090180145,"threshold_uncertainty_score":0.9982393},"labels":[],"label_agreement":null},{"id":"W4221029596","doi":"10.2147/ceor.s348138","title":"Health-Related Quality of Life of Patients Presenting to the Emergency Department with a Musculoskeletal Disorder","year":2022,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"HEC Montréal; Centre hospitalier de l'Université Laval; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre for Interdisciplinary Research in Rehabilitation; Université Laval; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean","funders":"Canadian Institutes of Health Research; Université Laval","keywords":"Emergency department; Quality of life (healthcare); Musculoskeletal pain; Musculoskeletal disorder; Musculoskeletal injury","score_opus":0.05618692627382284,"score_gpt":0.4324110061625774,"score_spread":0.37622407988875456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221029596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989127,0.00021982165,0.000008678489,0.008781051,0.00012614185,0.0014157583,0.00005031262,0.000005646489,0.00026561704],"genre_scores_gemma":[0.9990482,0.000100007375,0.00010949394,0.00013593023,0.00001546305,0.00010406056,0.000048290796,0.000014493884,0.0004240785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742484,0.00063084316,0.0010415157,0.000262844,0.0003847252,0.00025523003],"domain_scores_gemma":[0.99826914,0.000719993,0.00027942046,0.00037465667,0.00018344769,0.00017333703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004103319,0.000090935166,0.00048748832,0.00014308005,0.0002394028,0.0000050291696,0.00013691232,0.00003060412,0.00023320713],"category_scores_gemma":[0.0009014304,0.000057509522,0.00016203799,0.00023512967,0.00015449991,0.000029973182,0.00029035474,0.0003078409,0.0000037190377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025523786,0.00047320273,0.98543894,0.0005558299,0.00011566996,8.940351e-8,0.00095332693,0.00011272493,0.0000056338254,0.0005091651,0.00034327572,0.011236918],"study_design_scores_gemma":[0.001415863,0.0012588481,0.99396455,0.0000087687185,0.000007550182,1.2868196e-7,0.0013615333,0.0002773207,0.0000010091075,0.00015748471,0.0014869927,0.000059920527],"about_ca_topic_score_codex":0.00045321442,"about_ca_topic_score_gemma":0.00021753022,"teacher_disagreement_score":0.011176998,"about_ca_system_score_codex":0.000059526035,"about_ca_system_score_gemma":0.00018708374,"threshold_uncertainty_score":0.25534546},"labels":[],"label_agreement":null},{"id":"W4225728238","doi":"10.2147/ceor.s360741","title":"Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England","year":2022,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Standard of care; Perspective (graphical); Coronavirus disease 2019 (COVID-19); National standard; Disease; Coronavirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","score_opus":0.15323440834654267,"score_gpt":0.5107666465830766,"score_spread":0.3575322382365339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225728238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95942354,0.0049133245,0.000011576429,0.0065387064,0.000052854473,0.0028580832,0.026185025,0.0000037852392,0.000013131187],"genre_scores_gemma":[0.9932443,0.005873556,0.00017752968,0.00029907902,0.000039338316,0.0001170806,0.00021325958,0.000024500248,0.000011342963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682957,0.00041485985,0.0012378916,0.00051664066,0.0007117906,0.00028926483],"domain_scores_gemma":[0.9733472,0.023274904,0.00072885706,0.0005521094,0.0017540455,0.00034287438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020503323,0.00019773505,0.0017293692,0.0001253634,0.00030367257,0.000011250605,0.0002940749,0.000052051124,0.00004292334],"category_scores_gemma":[0.0030304634,0.00011398304,0.00023397,0.00012457905,0.0013966537,0.000041074,0.0003461046,0.00026672691,1.08997156e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06535175,0.0003960711,0.91234964,0.00089281605,0.0010521105,7.6155965e-7,0.012960955,0.0023027125,1.9188973e-7,0.00051522563,0.000039751034,0.0041379896],"study_design_scores_gemma":[0.04019622,0.026312837,0.9061113,0.00011345185,0.0001916409,1.3148852e-7,0.023098204,0.000493571,0.000009211637,0.0003343823,0.003025008,0.000114026094],"about_ca_topic_score_codex":0.0062680347,"about_ca_topic_score_gemma":0.005850726,"teacher_disagreement_score":0.0338208,"about_ca_system_score_codex":0.0014998219,"about_ca_system_score_gemma":0.006219461,"threshold_uncertainty_score":0.9994143},"labels":[],"label_agreement":null},{"id":"W4285744912","doi":"10.2147/ceor.s338225","title":"Economic Burden of COVID-19: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Héma-Québec","funders":"","keywords":"Medicine; MEDLINE; Psychological intervention; Cochrane Library; Systematic review; Population; Pandemic; Health care; Coronavirus disease 2019 (COVID-19); Data extraction; Productivity; Environmental health; Meta-analysis; Pathology; Disease; Infectious disease (medical specialty); Nursing","score_opus":0.45678125092406846,"score_gpt":0.6258804148379368,"score_spread":0.1690991639138683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285744912","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018967114,0.9869724,9.95451e-7,0.004734102,0.00028290364,0.006908162,0.00029989012,0.000028826385,0.0007537885],"genre_scores_gemma":[0.000008969899,0.99281,0.0000255993,0.0036420035,0.00018825513,0.0006840787,0.00016914922,0.00009712014,0.002374786],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99360734,0.0012161018,0.0032609964,0.0008626822,0.00037061606,0.00068228465],"domain_scores_gemma":[0.9837364,0.012123364,0.0011371311,0.0016485634,0.00008781946,0.001266743],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010708646,0.00047351586,0.00832721,0.0009151132,0.0002444895,0.000056653895,0.00063837453,0.00037020433,0.0022857725],"category_scores_gemma":[0.01029017,0.00036583288,0.0013034373,0.00025342288,0.0002822933,0.000060379436,0.0007473003,0.0016127139,0.0002592232],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001618048,0.00003682724,0.000070277136,0.8995269,0.00043450313,0.000033145225,0.000094048904,3.8227031e-7,2.7716494e-9,0.00047024482,0.0023890382,0.09692846],"study_design_scores_gemma":[0.00049756875,0.00030881993,0.000008119302,0.16404971,0.0014577956,0.00011570887,0.00012995944,0.000016800182,7.743478e-9,0.000107759144,0.8330748,0.00023290329],"about_ca_topic_score_codex":0.0008372122,"about_ca_topic_score_gemma":0.000069825124,"teacher_disagreement_score":0.8306858,"about_ca_system_score_codex":0.0022593183,"about_ca_system_score_gemma":0.012085675,"threshold_uncertainty_score":0.99987936},"labels":[],"label_agreement":null},{"id":"W4322744955","doi":"10.2147/ceor.s397671","title":"Comprehensive Custom-Pak® in Cataract and Vitreoretinal Surgery in Canadian Hospitals: Time and Budget Impact Analysis","year":2023,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alcon (Canada); Kensington Health","funders":"","keywords":"Medicine; Cataract surgery; Operations management; Medical emergency; Surgery; Engineering","score_opus":0.12812742681287384,"score_gpt":0.5417005292994408,"score_spread":0.413573102486567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322744955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99217415,0.00023732395,0.0000010628711,0.006610909,0.00007563229,0.000485393,0.00014225447,0.000012956485,0.00026031994],"genre_scores_gemma":[0.9946238,0.00400629,0.00010834568,0.00043454958,0.000039162165,0.000046018293,0.0002512486,0.000018542953,0.00047203663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971733,0.00075868616,0.00074706017,0.0004177312,0.00009616112,0.0008070521],"domain_scores_gemma":[0.99439675,0.0046289405,0.000080367456,0.00023118743,0.00016015279,0.0005025979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005251522,0.00013576337,0.0006176377,0.0019996734,0.0005013278,0.00007705512,0.00007965511,0.00023464442,0.00014835529],"category_scores_gemma":[0.00087456394,0.00012272295,0.00006258141,0.00093238504,0.0001380375,0.00015285387,0.00012056134,0.0007580866,0.000099135104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002282676,0.000010158808,0.9939076,0.00004692331,0.000041593532,0.000016767532,0.0010884425,0.00047860606,0.0000012812609,0.00010490992,0.0004125829,0.0038683459],"study_design_scores_gemma":[0.00034546095,0.00003223918,0.9074987,0.000032401822,0.00000827912,5.9525235e-7,0.0012241773,0.08976407,1.5805885e-7,0.00011143848,0.0008709312,0.000111523455],"about_ca_topic_score_codex":0.30468702,"about_ca_topic_score_gemma":0.41213438,"teacher_disagreement_score":0.10744735,"about_ca_system_score_codex":0.00031786016,"about_ca_system_score_gemma":0.0012704488,"threshold_uncertainty_score":0.6999431},"labels":[],"label_agreement":null},{"id":"W4323568228","doi":"10.2147/ceor.s397154","title":"Glucarpidase for Treating Adults with Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis","year":2023,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Reimbursement; Intensive care medicine; Renal function; Pharmacology; Internal medicine; Health care","score_opus":0.07081217146715012,"score_gpt":0.44605899172921887,"score_spread":0.37524682026206874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323568228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98868966,0.0000139663725,0.0074991737,0.0019283871,0.000074321404,0.0014101075,0.00011828238,0.00008762444,0.00017847627],"genre_scores_gemma":[0.99402773,0.000045022927,0.0032352179,0.0002269201,0.00026178305,0.00027330965,0.00059229333,0.00005819482,0.0012795428],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99738044,0.0002038327,0.000663636,0.0008119016,0.0002786421,0.00066156883],"domain_scores_gemma":[0.99425143,0.0040683933,0.00013214415,0.00056585955,0.00042950083,0.00055268337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003524963,0.00021713278,0.00070687314,0.0014412736,0.0003495825,0.0001631358,0.00016540506,0.00016903669,0.000094523275],"category_scores_gemma":[0.0008351176,0.000178814,0.00020661997,0.0008161491,0.00011660936,0.00024954943,0.00013932635,0.00026311094,0.000117761694],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040572934,0.0004223224,0.184535,0.00043911533,0.0063865627,0.00014631546,0.003919841,0.24208799,0.00048409228,0.001255804,0.0015866542,0.5181634],"study_design_scores_gemma":[0.004937885,0.0024122444,0.22916892,0.000025462561,0.0003552556,0.000005999994,0.0009200446,0.7612538,0.00010010504,0.00017207643,0.00047463021,0.0001735977],"about_ca_topic_score_codex":0.00030379277,"about_ca_topic_score_gemma":0.0008060535,"teacher_disagreement_score":0.51916575,"about_ca_system_score_codex":0.00077189464,"about_ca_system_score_gemma":0.0005510275,"threshold_uncertainty_score":0.72918236},"labels":[],"label_agreement":null},{"id":"W4362721751","doi":"10.2147/ceor.s401003","title":"Holistic View of Autografting Patients by Percentage of Total Body Surface Area Burned: Medical Record Abstraction Integrated with Administrative Claims","year":2023,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Burn Injury Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medical record; Medicine; Total body surface area; Documentation; Retrospective cohort study; Observational study; Health care; Cohort; Diabetes mellitus; Emergency medicine; Population; Medical emergency; Surgery; Internal medicine; Environmental health","score_opus":0.12201657164370706,"score_gpt":0.4517683984514093,"score_spread":0.32975182680770226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362721751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627364,0.000053330088,0.00001297119,0.0010817198,0.00019544468,0.0005559867,0.00009003427,0.000034194454,0.0017026587],"genre_scores_gemma":[0.9954799,0.001177334,0.000121752375,0.00008762905,0.000026845144,0.000011084343,0.00024231372,0.000028085331,0.002825103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977526,0.00011376493,0.0008808654,0.0003816615,0.0004829806,0.00038811332],"domain_scores_gemma":[0.9977778,0.0011882324,0.0002549051,0.0002924181,0.00024125415,0.00024534587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017121327,0.00018901438,0.0007362505,0.00023943973,0.00009454614,0.00003561096,0.00015231628,0.00017054792,0.00044239676],"category_scores_gemma":[0.0004937186,0.00013975527,0.00012632945,0.000283292,0.00039881215,0.0001169414,0.00015460968,0.0005881534,0.000029105431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005681091,0.00031695812,0.9678714,0.00036203585,0.00024415937,0.00001711413,0.00020241644,0.000003259669,0.000082279395,0.00019193455,0.0021675795,0.027972715],"study_design_scores_gemma":[0.0034373384,0.0018491165,0.9837227,0.00033914568,0.00007418218,0.000004117221,0.0031859353,0.0030935353,0.0002512412,0.000093423114,0.0037500914,0.00019918304],"about_ca_topic_score_codex":0.00021142015,"about_ca_topic_score_gemma":0.00007017187,"teacher_disagreement_score":0.027773533,"about_ca_system_score_codex":0.000078651545,"about_ca_system_score_gemma":0.00021506521,"threshold_uncertainty_score":0.56990546},"labels":[],"label_agreement":null},{"id":"W4366588956","doi":"10.2147/ceor.s377935","title":"Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada","year":2023,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Montreal Heart Institute; St. Michael's Hospital; Robarts Clinical Trials; Université de Montréal","funders":"HLS Therapeutics; Amryt Pharma; Sanofi; Kowa Company; Regeneron Pharmaceuticals; Novo Nordisk; Servier; Amgen; Pfizer; Esperion Therapeutics; Ultragenyx Pharmaceutical; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Bioinformatics; Biology","score_opus":0.10892320106107337,"score_gpt":0.413451090303862,"score_spread":0.3045278892427886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366588956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952282,0.0015396227,0.000021459924,0.0003402059,0.0002793981,0.0024759544,0.000057632195,0.0000019779839,0.000055582896],"genre_scores_gemma":[0.99453133,0.0051432834,0.000020187874,0.000012047077,0.000044062977,0.00017230092,0.000006727563,0.0000143687,0.00005570916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982171,0.00046041046,0.0005066129,0.00021945522,0.00035646427,0.0002399547],"domain_scores_gemma":[0.99723643,0.0016148194,0.00013913913,0.0007542888,0.00019772742,0.0000575949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010310459,0.00008315237,0.00065540685,0.000097789925,0.00007422894,0.0000023617597,0.00018371663,0.00006857456,0.0000037049015],"category_scores_gemma":[0.00079406245,0.000049140643,0.00054280576,0.00026308864,0.00013522869,0.000021395224,0.00014507766,0.00031997784,5.66695e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004283032,0.000062728046,0.90553457,0.0014535683,0.0015966775,8.8846616e-7,0.00018962736,0.0017003873,0.00033515503,0.00008443458,0.00015871381,0.08845498],"study_design_scores_gemma":[0.0023157366,0.00008530341,0.9873102,0.00013113275,0.00013011662,0.0000029933562,0.0009208299,0.0009542906,0.0052216714,0.00015513325,0.0027250263,0.000047589583],"about_ca_topic_score_codex":0.34629172,"about_ca_topic_score_gemma":0.04621579,"teacher_disagreement_score":0.30007592,"about_ca_system_score_codex":0.00024507425,"about_ca_system_score_gemma":0.0012849256,"threshold_uncertainty_score":0.9711883},"labels":[],"label_agreement":null},{"id":"W4381988377","doi":"10.2147/ceor.s410082","title":"Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence","year":2023,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Sarcoidosis; Internal medicine; Infliximab; Polymyositis; Dermatomyositis; Rheumatoid arthritis; Disease","score_opus":0.3911887662179583,"score_gpt":0.6079644652209814,"score_spread":0.21677569900302307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381988377","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013425513,0.99365634,2.2885962e-7,0.001162631,0.00028033013,0.0027686942,0.00012979955,0.000029393193,0.00063004455],"genre_scores_gemma":[0.000014481363,0.9931756,0.0000641588,0.0003225835,0.00026636687,0.00021815341,0.000111421214,0.00011318222,0.0057140556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925609,0.0012101395,0.0039894613,0.0011826388,0.00036866526,0.00068818795],"domain_scores_gemma":[0.989192,0.007813762,0.0008999593,0.0012418086,0.00036395533,0.00048851786],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.013876936,0.0005326098,0.00672627,0.0007208856,0.00019362061,0.00013686887,0.00056956627,0.000865563,0.00026965392],"category_scores_gemma":[0.006470227,0.00039335302,0.0012153327,0.00037975586,0.001252815,0.0002648231,0.0010876557,0.0030794183,0.00037886394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000796341,0.000056985802,0.0027527397,0.24903424,0.00066702045,0.00006921007,0.0001905576,1.7891725e-8,3.0250437e-8,0.00027875823,0.006831792,0.740039],"study_design_scores_gemma":[0.0007187606,0.00041811488,0.0021715949,0.2440531,0.00030214695,0.00006420104,0.00017266037,0.000031161457,1.0410527e-7,0.00010245183,0.7516786,0.00028714843],"about_ca_topic_score_codex":0.000030285395,"about_ca_topic_score_gemma":0.000017177035,"teacher_disagreement_score":0.74484676,"about_ca_system_score_codex":0.00012371775,"about_ca_system_score_gemma":0.0030032739,"threshold_uncertainty_score":0.9998518},"labels":[],"label_agreement":null},{"id":"W4386513946","doi":"10.2147/ceor.s416562","title":"The Cost of Maternal Complications and Its Associated Factors Among Mothers Attending Public Hospitals in Harari Region and Dire Dawa City Administration, Eastern Ethiopia: An Institution-Based Cross-Sectional Study","year":2023,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Global Maternal and Child Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Haramaya University","keywords":"Medicine; Cross-sectional study; Public health; Health facility; Family medicine; Pediatrics; Demography; Environmental health; Health services; Nursing; Population","score_opus":0.2003615287841409,"score_gpt":0.47434215941726776,"score_spread":0.27398063063312683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386513946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966009,0.000027284963,0.0000025481543,0.0023288964,0.00009156456,0.0007318081,0.00005884183,0.000018243774,0.0001398661],"genre_scores_gemma":[0.99952006,0.0001408242,0.000002613191,0.00009001411,0.000020112155,0.000029168279,0.00003854762,0.000008803388,0.0001498822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863267,0.00012999149,0.0005105623,0.00028890194,0.0001775847,0.0002602742],"domain_scores_gemma":[0.99876666,0.00055821193,0.00014556649,0.00016310069,0.00017427086,0.00019219254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016084522,0.00010059367,0.0002452534,0.0001688041,0.0004594762,0.00023390469,0.000110278925,0.00010249127,0.000003508625],"category_scores_gemma":[0.00037743244,0.00007455043,0.00003145067,0.00014247124,0.0003181928,0.00016354487,0.00008337991,0.0003220409,0.000002412892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056901947,0.00012009387,0.9981387,0.000033552282,0.00003539264,0.0000033105064,0.00017474662,0.000008137298,0.0000027300157,0.0011061459,0.000006013188,0.00031425667],"study_design_scores_gemma":[0.0013015633,0.00028963006,0.99462396,0.000031451214,0.0000049011205,0.0000023350647,0.00059740373,0.002795175,0.000006302012,0.0002508154,0.000035902183,0.000060584087],"about_ca_topic_score_codex":0.0006199712,"about_ca_topic_score_gemma":0.0014395872,"teacher_disagreement_score":0.0035147823,"about_ca_system_score_codex":0.00009526982,"about_ca_system_score_gemma":0.00018898804,"threshold_uncertainty_score":0.3533966},"labels":[],"label_agreement":null},{"id":"W4387710816","doi":"10.2147/ceor.s428466","title":"Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis","year":2023,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Cohort; Sarcoidosis; Health care; Internal medicine","score_opus":0.22108551711672444,"score_gpt":0.5209349341320468,"score_spread":0.2998494170153224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387710816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945462,0.0014182098,0.000008952942,0.00050225813,0.00015544414,0.0027932555,0.00038855337,0.000010234133,0.00017692891],"genre_scores_gemma":[0.98857355,0.010628753,0.00017343671,0.000006751342,0.000035694557,0.0003566519,0.000038901893,0.000027503704,0.00015877691],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982264,0.00017849333,0.0005892873,0.0002915972,0.00033152426,0.000382677],"domain_scores_gemma":[0.98458254,0.014077663,0.00014384929,0.0005315823,0.0005460063,0.00011837913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020750312,0.00014263409,0.0009888234,0.0003080156,0.000121677105,0.000015186299,0.00019991735,0.00010538148,0.000027610557],"category_scores_gemma":[0.00077906554,0.00009136893,0.0003599743,0.0003008498,0.00046374864,0.00004368468,0.0001044677,0.00013655967,0.000005135649],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035778902,0.00086410757,0.43268558,0.0061725695,0.0017698798,0.000004298152,0.0032411898,0.00021486141,0.007155831,0.0014049003,0.000104362785,0.5106035],"study_design_scores_gemma":[0.030794766,0.027867515,0.7926577,0.00053413,0.0003413009,0.0000016839597,0.013338572,0.0029950065,0.12410515,0.00035144735,0.006772606,0.00024016989],"about_ca_topic_score_codex":0.00007395175,"about_ca_topic_score_gemma":0.000080039725,"teacher_disagreement_score":0.51036334,"about_ca_system_score_codex":0.00020008387,"about_ca_system_score_gemma":0.0003067882,"threshold_uncertainty_score":0.3725917},"labels":[],"label_agreement":null},{"id":"W4390826881","doi":"10.2147/ceor.s434971","title":"Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14)","year":2024,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Acute Kidney Injury Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"Baxter Healthcare Corporation","keywords":"Medicine; Acute kidney injury; Cohort; Intensive care medicine; Quality-adjusted life year; Dialysis; Emergency medicine; Cost effectiveness; Internal medicine","score_opus":0.2368819059464225,"score_gpt":0.45608396091265435,"score_spread":0.21920205496623185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390826881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728202,0.00037735238,0.0000061259075,0.021395385,0.00041676543,0.0014048873,0.0011655039,0.000029233173,0.0023844955],"genre_scores_gemma":[0.99545586,0.0020841,0.000060481612,0.00033863637,0.0001499196,0.00016340544,0.000036999707,0.000048066566,0.0016625369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712604,0.00029743847,0.00095659174,0.000578133,0.00041588262,0.0006258871],"domain_scores_gemma":[0.99515456,0.002738117,0.00012756638,0.0010804231,0.000422569,0.00047678137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072111036,0.00023410597,0.00067567365,0.00032765072,0.0003343779,0.00013104403,0.00044903328,0.00013810894,0.00020442465],"category_scores_gemma":[0.00273456,0.00013222433,0.0004357386,0.0005001407,0.0011808336,0.00021517041,0.0008769324,0.0012857269,0.000020368605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003840063,0.00062735984,0.5106677,0.0034073326,0.0073481076,0.000989655,0.00800269,0.0000018091695,0.0029061278,0.0010374732,0.08911919,0.3720525],"study_design_scores_gemma":[0.013464764,0.0057388316,0.50022984,0.0025062175,0.0029814576,0.0062188646,0.033413697,0.22366887,0.025452685,0.0015443077,0.1833325,0.0014479621],"about_ca_topic_score_codex":0.00029585147,"about_ca_topic_score_gemma":0.000018605077,"teacher_disagreement_score":0.37060454,"about_ca_system_score_codex":0.00012406419,"about_ca_system_score_gemma":0.00076214294,"threshold_uncertainty_score":0.55859154},"labels":[],"label_agreement":null},{"id":"W4390987140","doi":"10.2147/ceor.s445141","title":"Budget Impact Analysis of Minimally Invasive versus Open Transforaminal Lumbar Interbody Fusion for Lumbar Degenerative Disease: A European Hospital Perspective","year":2024,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Spine and Intervertebral Disc Pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Lumbar; Surgery; Blood loss; Degenerative disc disease","score_opus":0.09880828495304093,"score_gpt":0.5021162951625385,"score_spread":0.4033080102094976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390987140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905265,0.0013024184,0.000105329374,0.0030800966,0.00026268145,0.0011832465,0.00062869734,0.00001609631,0.0028949075],"genre_scores_gemma":[0.99684376,0.0010521404,0.0003523057,0.00017302213,0.00011988189,0.000071312985,0.00022125787,0.000040999017,0.0011253465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980013,0.00020866907,0.0005885163,0.00068320846,0.00014021281,0.00037811673],"domain_scores_gemma":[0.99860495,0.0002521709,0.0000786643,0.0003523678,0.00038800534,0.00032386268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012934413,0.00021341097,0.00083469594,0.00065827306,0.00010418764,0.00018186135,0.0003488842,0.00008559155,0.0003207884],"category_scores_gemma":[0.00089513045,0.00016652198,0.00076794095,0.000351605,0.00034552944,0.00022105836,0.00034631143,0.0003393328,0.000027250338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017330334,0.0059803897,0.55656,0.0027879954,0.069669336,0.0020040874,0.056286592,0.00013294195,0.027066156,0.07413693,0.040534597,0.14751065],"study_design_scores_gemma":[0.0036210823,0.0068927817,0.97556543,0.00012731845,0.0011984996,0.0000027826288,0.0034967153,0.0078079132,0.00029300625,0.00039021895,0.00037469357,0.00022954668],"about_ca_topic_score_codex":0.00018914252,"about_ca_topic_score_gemma":0.00040569945,"teacher_disagreement_score":0.41900545,"about_ca_system_score_codex":0.00024135331,"about_ca_system_score_gemma":0.0005066523,"threshold_uncertainty_score":0.67905694},"labels":[],"label_agreement":null},{"id":"W4391264145","doi":"10.2147/ceor.s443077","title":"Methods used to account for caregivers’ sex and gender within studies examining the financial burden of caregivers of children and adolescents : Results from a scoping review","year":2024,"lang":"en","type":"review","venue":"ClinicoEconomics and Outcomes Research","topic":"Family Support in Illness","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bibliothèque et Archives nationales du Québec; Centres Intégré Universitaires de Santé et de Services Sociaux; Université du Québec à Rimouski; Université Laval","funders":"","keywords":"Medicine; MEDLINE; Data extraction; Narrative review; Family medicine","score_opus":0.426790582209805,"score_gpt":0.570804507196553,"score_spread":0.14401392498674798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391264145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009918773,0.9847238,0.00000619025,0.00027911988,0.00052496005,0.0037689924,0.0006956147,0.000008803553,0.00007374797],"genre_scores_gemma":[0.0010380901,0.9976038,0.0007720454,0.000061093626,0.00019315611,0.000119459095,0.000026936978,0.000035684592,0.00014976792],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9959841,0.0011081322,0.0013571852,0.0008267487,0.00031337017,0.00041049463],"domain_scores_gemma":[0.9904701,0.008055464,0.00058348523,0.00047038583,0.00026262825,0.00015793426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012342355,0.00030750106,0.002438743,0.00024854345,0.00037299385,0.00011871572,0.00058548397,0.00027945708,0.0000037302711],"category_scores_gemma":[0.0064142407,0.00021602065,0.00024052123,0.00026082667,0.0010116302,0.000098852244,0.00093805057,0.00051035534,0.0000015808702],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004289739,0.000013767994,0.0016100743,0.058858864,0.0007251539,0.0000025793486,0.09103975,0.0000014430849,9.229669e-8,0.00027890445,0.0011692314,0.84625727],"study_design_scores_gemma":[0.003929281,0.0005655725,0.0043444354,0.602423,0.005517826,0.0000057855214,0.15739886,0.00005208425,0.0000024877356,0.0024223656,0.22125822,0.0020800345],"about_ca_topic_score_codex":0.0021819985,"about_ca_topic_score_gemma":0.0014525368,"teacher_disagreement_score":0.8441772,"about_ca_system_score_codex":0.00016152964,"about_ca_system_score_gemma":0.0011748982,"threshold_uncertainty_score":0.88090664},"labels":[],"label_agreement":null},{"id":"W4398785298","doi":"10.2147/ceor.s462872","title":"Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in Canada","year":2024,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Arthur B. McDonald-Canadian Astroparticle Physics Research Institute; University of Ottawa; Wilfrid Laurier University; Fraser Institute; Fraser Health; Canadian Institute for Health Information","funders":"","keywords":"Timeline; Negotiation; Reimbursement; Medicine; Alliance; Family medicine; Agency (philosophy); Public relations; Health care; Political science; Law","score_opus":0.5314994188845462,"score_gpt":0.6262702012041306,"score_spread":0.09477078231958436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398785298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85589397,0.0082791755,0.0007104408,0.13170934,0.000761474,0.0012765903,0.0004683575,0.000018083823,0.0008825655],"genre_scores_gemma":[0.9916078,0.0023471224,0.0026964897,0.0024554892,0.000078344325,0.00022829072,0.00003158795,0.000032985045,0.00052192115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948603,0.0002715023,0.0037009874,0.0005983425,0.000059687936,0.0005092179],"domain_scores_gemma":[0.992459,0.0062963073,0.00070058287,0.00031264615,0.00008472175,0.00014677062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023626989,0.0001333222,0.0011850793,0.0009023436,0.00014885438,0.00006529725,0.00022466702,0.0001576964,0.000055989694],"category_scores_gemma":[0.002019831,0.00015911342,0.00005443289,0.0002799866,0.00014601737,0.00020158231,0.00014402189,0.00035520433,0.000031137828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017998524,0.00008596428,0.6884381,0.0012367708,0.000117183445,8.826e-7,0.0010666976,0.00006869557,5.159478e-7,0.27222785,0.006149963,0.03058933],"study_design_scores_gemma":[0.0034170302,0.0006420653,0.3868418,0.0003031892,0.000009359928,0.00000836562,0.016229684,0.12459253,0.000004572824,0.14310668,0.32421446,0.0006302548],"about_ca_topic_score_codex":0.20212309,"about_ca_topic_score_gemma":0.25321728,"teacher_disagreement_score":0.31806448,"about_ca_system_score_codex":0.0018674541,"about_ca_system_score_gemma":0.004005539,"threshold_uncertainty_score":0.818869},"labels":[],"label_agreement":null},{"id":"W4402533942","doi":"10.2147/ceor.s476426","title":"Adjusting Historical Costs for Inflation with the Use of Standardized Automated Tools","year":2024,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Economic, financial, and policy analysis","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Université Laval; Centre hospitalier de l'Université Laval","funders":"Fondation des pompiers du Québec pour les grands brûlés; Réseau Québécois de Recherche sur les Médicaments","keywords":"Medicine; Inflation (cosmology); Data science; Computer science","score_opus":0.30047795636472757,"score_gpt":0.4189119704325253,"score_spread":0.11843401406779774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402533942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813513,0.002386166,0.003817309,0.008153231,0.0004902187,0.000862813,0.00095707795,0.000106168685,0.0018756998],"genre_scores_gemma":[0.99371135,0.0009703042,0.0016037446,0.0002925329,0.00021719512,0.00010730748,0.00004231763,0.000051243096,0.0030039914],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804604,0.000055822253,0.0009827419,0.00048208638,0.000045092016,0.00038822644],"domain_scores_gemma":[0.99499035,0.0041472875,0.00026914966,0.0003841466,0.00011650634,0.00009258075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003096858,0.00016085159,0.0006912487,0.0004367839,0.00025562025,0.0004554491,0.00023042966,0.00014692458,0.000049354923],"category_scores_gemma":[0.00091325754,0.00012863246,0.00024161696,0.00025651403,0.0001801748,0.00047926372,0.00009799068,0.00030161988,0.00004695235],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005119862,0.0001106424,0.2429196,0.00048017976,0.0010346307,0.0000055078003,0.0016754755,0.0017525029,0.000023573946,0.62461674,0.043528643,0.08334054],"study_design_scores_gemma":[0.0013905548,0.00038927226,0.051178377,0.000054933185,0.000054319575,0.000002820687,0.00014560178,0.1958485,0.00003328675,0.006535353,0.7439904,0.00037653613],"about_ca_topic_score_codex":0.0006914617,"about_ca_topic_score_gemma":0.00031661874,"teacher_disagreement_score":0.7004618,"about_ca_system_score_codex":0.00052320346,"about_ca_system_score_gemma":0.00011977067,"threshold_uncertainty_score":0.52454793},"labels":[],"label_agreement":null},{"id":"W4408692096","doi":"10.2147/ceor.s504462","title":"The Burden of Obesity in Saudi Arabia: A Real-World Cost-of-Illness Study","year":2025,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Technology Assessment international; Mahidol University; Prince Sattam bin Abdulaziz University","keywords":"Medicine; Obesity; Internal medicine","score_opus":0.08310755098022952,"score_gpt":0.4498267128533429,"score_spread":0.3667191618731134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408692096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887553,0.00034859715,0.0000022084052,0.0034769445,0.00036032387,0.0011458154,0.0000073454808,0.000007675529,0.0058958097],"genre_scores_gemma":[0.990515,0.0019325569,0.000025689504,0.00008331273,0.000057151803,0.00004790042,0.0000023535804,0.000010297315,0.00732574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977952,0.00032269378,0.0010111008,0.00032023428,0.00019068304,0.00036005405],"domain_scores_gemma":[0.9912355,0.007715993,0.00015244535,0.00061611226,0.00018817077,0.00009175577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060992176,0.00012883138,0.0008446142,0.0005264847,0.00015958138,0.00002889026,0.00026412672,0.000099149256,0.000029625737],"category_scores_gemma":[0.0013027363,0.00008818533,0.00015806884,0.0005658881,0.00034112763,0.0000488865,0.00032510192,0.00053866615,0.0000056083786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000387004,0.00032475474,0.96062106,0.00010469502,0.00014784004,0.000009355852,0.00069096586,0.0000106836815,0.000004709254,0.0033081186,0.0004195394,0.033971302],"study_design_scores_gemma":[0.0022911076,0.0001457929,0.9869377,0.00005827936,0.00004097799,6.543663e-7,0.0044674813,0.00032047622,0.00007007649,0.0016793136,0.0039106854,0.000077453646],"about_ca_topic_score_codex":0.002781318,"about_ca_topic_score_gemma":0.0017333631,"teacher_disagreement_score":0.03389385,"about_ca_system_score_codex":0.000101582395,"about_ca_system_score_gemma":0.00041100313,"threshold_uncertainty_score":0.42045397},"labels":[],"label_agreement":null},{"id":"W4412557155","doi":"10.2147/ceor.s527169","title":"Cost-Utility Analysis of Metabolic Bariatric Surgery for Individuals with Obesity in Saudi Arabia","year":2025,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Technology Assessment international; Mahidol University; Prince Sattam bin Abdulaziz University","keywords":"Medicine; Obesity; Obesity Surgery; Bioinformatics; Metabolic syndrome; General surgery; Weight loss; Pathology; Gastric bypass; Biology","score_opus":0.11198586571950932,"score_gpt":0.42964525866890035,"score_spread":0.31765939294939105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412557155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99483514,0.0012043889,0.00020833906,0.0018229723,0.00016570718,0.0010541518,0.000102286285,0.000012304913,0.00059469295],"genre_scores_gemma":[0.9963698,0.0015178076,0.0005936459,0.0004484815,0.000033626362,0.00009976561,0.000058138536,0.0000127027515,0.00086607825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734014,0.00026886005,0.0011097523,0.0005549518,0.00020692548,0.00051936955],"domain_scores_gemma":[0.9856843,0.013097678,0.00019582274,0.0005943169,0.00025954968,0.00016837243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008468656,0.00019088674,0.0019737834,0.0027089403,0.00011905762,0.000043503725,0.00016668225,0.00021594952,0.000103124155],"category_scores_gemma":[0.002349733,0.00014988218,0.00052538613,0.0022206113,0.00024082667,0.00009925842,0.00014822815,0.00042974044,0.0000032352846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042579835,0.00028349235,0.9770189,0.00017290434,0.0017251746,0.0000031799188,0.00008966185,0.000013412121,9.86451e-7,0.002351099,0.0003334673,0.017581945],"study_design_scores_gemma":[0.0017014949,0.000046240286,0.989204,0.000026507802,0.0010303977,7.3107844e-7,0.00019745003,0.0015792763,0.000038764232,0.00073451543,0.0053169425,0.00012370135],"about_ca_topic_score_codex":0.0003103135,"about_ca_topic_score_gemma":0.00045274603,"teacher_disagreement_score":0.017458243,"about_ca_system_score_codex":0.00005682193,"about_ca_system_score_gemma":0.00069940445,"threshold_uncertainty_score":0.6112018},"labels":[],"label_agreement":null},{"id":"W4413771329","doi":"10.2147/ceor.s522756","title":"Real-World Disability Outcomes Among Patients Treated with Cariprazine vs Other Atypical Antipsychotics as Adjunctive Treatment for Major Depressive Disorder","year":2025,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Treatment of Major Depression","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Psychiatry; Adjunctive treatment; Major depressive disorder; Aripiprazole; Schizophrenia (object-oriented programming); Pediatrics; Internal medicine; Cognition","score_opus":0.04925114078597439,"score_gpt":0.4311459313388048,"score_spread":0.38189479055283043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413771329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911906,0.0000643564,0.00001844722,0.00216676,0.00017574412,0.0035188296,0.00022155145,0.00006329057,0.0025803896],"genre_scores_gemma":[0.98410994,0.00025984962,0.00046761218,0.00028066232,0.00004911218,0.00052070053,0.00020303173,0.00006752503,0.014041579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721056,0.00017620799,0.0007023065,0.0010003699,0.00026556218,0.0006449876],"domain_scores_gemma":[0.99581456,0.002463961,0.00016866591,0.0009124499,0.0003135009,0.00032686602],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041266976,0.00043874927,0.0011536533,0.00029128228,0.00034341877,0.000094592026,0.00018327813,0.00023140383,0.000096004886],"category_scores_gemma":[0.00041144845,0.00027384548,0.00029587757,0.00023065793,0.00072048453,0.00013956145,0.00015426807,0.00034477157,0.000021251044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014500669,0.0024525516,0.96592087,0.00008351184,0.001030701,0.000009694169,0.00008573147,0.0000047247513,0.000002163486,0.00049580255,0.00039179507,0.015021779],"study_design_scores_gemma":[0.024973476,0.0023947284,0.96819574,0.00010554399,0.0003908723,9.537799e-7,0.00009181217,0.00024454348,0.00010571703,0.0005523386,0.0027122067,0.00023205837],"about_ca_topic_score_codex":0.0012775443,"about_ca_topic_score_gemma":0.0037570165,"teacher_disagreement_score":0.01478972,"about_ca_system_score_codex":0.00059021445,"about_ca_system_score_gemma":0.00019332617,"threshold_uncertainty_score":0.9999714},"labels":[],"label_agreement":null},{"id":"W4413777371","doi":"10.2147/ceor.s530832","title":"Early Diagnosis and Timely Terlipressin in Hepatorenal Syndrome Improves Projected Outcomes and Lowers Cost","year":2025,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals; Ultragenyx Pharmaceutical; Gilead Sciences","keywords":"Terlipressin; Hepatorenal syndrome; Medicine; Intensive care medicine; Internal medicine; Cirrhosis","score_opus":0.05124886025677959,"score_gpt":0.4158430063038175,"score_spread":0.3645941460470379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413777371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99598145,0.00065133465,0.0000019765805,0.0018785263,0.000084712796,0.0009164142,0.00005003581,0.000017829936,0.000417717],"genre_scores_gemma":[0.99580425,0.0027752381,0.00007892576,0.00043466603,0.000012451595,0.00013669333,0.00002442118,0.000014441945,0.0007188945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986452,0.00008686566,0.00040055648,0.00043057898,0.000115521616,0.00032126906],"domain_scores_gemma":[0.9985015,0.0010073404,0.00004405926,0.0001970914,0.0000588089,0.00019124766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061975105,0.00015514348,0.00047325215,0.00044711665,0.00010824938,0.00013724907,0.00007504876,0.000127887,0.000018274208],"category_scores_gemma":[0.000092101654,0.0001271667,0.000056371595,0.00013113253,0.00027320397,0.00018032872,0.00010353529,0.00034295605,0.0000075021635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024312259,0.0001032556,0.9805688,0.00024374944,0.00020356933,0.000063977204,0.0003099539,1.0694556e-7,0.00003135311,0.00023770962,0.00003709883,0.01795729],"study_design_scores_gemma":[0.0035695701,0.00020842976,0.99467593,0.0001591129,0.0001011807,0.000008234448,0.00020962534,0.00030208405,0.000059817827,0.00042607985,0.00016441486,0.00011548654],"about_ca_topic_score_codex":0.00051675906,"about_ca_topic_score_gemma":0.00016023996,"teacher_disagreement_score":0.017841805,"about_ca_system_score_codex":0.000052409392,"about_ca_system_score_gemma":0.0001658911,"threshold_uncertainty_score":0.5185707},"labels":[],"label_agreement":null},{"id":"W4413833477","doi":"10.2147/ceor.s538395","title":"Beyond the COVID-19 Pandemic: Budget Impact Analysis of Remote Healthcare Delivery for Hypertension and Diabetes Mellitus Management in Thailand","year":2025,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"Thammasat University","keywords":"Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); Diabetes mellitus; Healthcare delivery; Diabetes management; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Health care; Telemedicine; Intensive care medicine; Virology; Internal medicine; Type 2 diabetes; Economic growth; Disease; Infectious disease (medical specialty); Outbreak","score_opus":0.1426317256737952,"score_gpt":0.5061215660319606,"score_spread":0.36348984035816534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413833477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97558385,0.002366878,0.00006701039,0.020556595,0.00006167971,0.0011729746,0.000080785365,0.0000073853093,0.000102811435],"genre_scores_gemma":[0.9743277,0.014809153,0.000552684,0.009922941,0.000024609659,0.0000328755,0.00013838029,0.000008890537,0.00018277856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984026,0.00013411175,0.00065908435,0.00032370738,0.00012672797,0.000353745],"domain_scores_gemma":[0.99694496,0.0023276506,0.00011171943,0.00030257693,0.000115712355,0.00019738798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033813706,0.00011232054,0.00062215026,0.0008473071,0.00014972457,0.000022257802,0.000089621404,0.000082293205,0.00001441149],"category_scores_gemma":[0.00032271259,0.00007292055,0.000120688936,0.00044164082,0.00015722295,0.00003885666,0.000120436154,0.00022247182,4.072996e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002562732,0.000029736955,0.8352913,0.00048007251,0.00057987205,0.0000024031788,0.00016771739,0.000007703063,0.0000064244564,0.0004673718,0.00096978707,0.1617413],"study_design_scores_gemma":[0.0039296504,0.00038122176,0.97139615,0.00002787485,0.0004199204,0.0000016727316,0.0012808607,0.008294036,0.0000070203714,0.00288509,0.011310773,0.00006574996],"about_ca_topic_score_codex":0.0012083623,"about_ca_topic_score_gemma":0.0015855149,"teacher_disagreement_score":0.16167554,"about_ca_system_score_codex":0.00016374575,"about_ca_system_score_gemma":0.00021148688,"threshold_uncertainty_score":0.29736137},"labels":[],"label_agreement":null},{"id":"W4414096736","doi":"10.2147/ceor.s533069","title":"Determinants of Economic Costs Following Road Traffic Injuries in Canada: A Quantile Regression Forests Machine Learning Approach","year":2025,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Traffic and Road Safety","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Quantile regression; Economic cost; Resource allocation; Road traffic; Quantile; Poison control; Resource (disambiguation); Economic model; Decision tree","score_opus":0.028497031037728705,"score_gpt":0.3532528931435239,"score_spread":0.3247558621057952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414096736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967943,0.001176805,0.000011039336,0.00004755558,0.00040125995,0.00025024926,0.000019943787,0.000028770493,0.0012700718],"genre_scores_gemma":[0.9987979,0.00074959407,0.00011783232,0.000012129949,0.000015122345,0.000021123325,0.00001183441,0.000025400557,0.0002490768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983635,0.00009487032,0.00070964906,0.00030205777,0.00009472849,0.0004351827],"domain_scores_gemma":[0.9990403,0.0005513065,0.000060119273,0.00023970354,0.00001687958,0.000091681446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010331451,0.00017808854,0.00061455317,0.00032580405,0.000118490716,0.00003420473,0.00025593306,0.00012220057,0.000008629699],"category_scores_gemma":[0.000096321426,0.00015986235,0.0001017011,0.000119854056,0.00007711868,0.00010345157,0.0001521228,0.0005458316,0.0000035046141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037715497,0.000017759188,0.8644672,0.00011360072,0.000037893024,0.000004530918,0.0001248284,0.033769682,0.0000025379081,0.00015325942,0.0000871298,0.10118387],"study_design_scores_gemma":[0.0007070765,0.000022415892,0.59505105,0.00007961263,0.000005512574,6.4352884e-7,0.00040195425,0.40318218,0.00003795526,0.000025585026,0.00036574306,0.00012029519],"about_ca_topic_score_codex":0.08518684,"about_ca_topic_score_gemma":0.7343817,"teacher_disagreement_score":0.64919484,"about_ca_system_score_codex":0.00059404154,"about_ca_system_score_gemma":0.00063618243,"threshold_uncertainty_score":0.920905},"labels":[],"label_agreement":null},{"id":"W7115193744","doi":"10.2147/ceor.s546850","title":"Cost-Utility Analysis of Renal Replacement Therapy Modalities in the Management of Severe Acute Kidney Injury in US Critically Ill Patients","year":2025,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Acute Kidney Injury Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Renal replacement therapy; Acute kidney injury; Critically ill; Modalities; Therapeutic modalities; Treatment modality","score_opus":0.08317054389346228,"score_gpt":0.4737478615328139,"score_spread":0.3905773176393516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7115193744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819344,0.000051901785,0.0000117504,0.0086347,0.00005230543,0.0015385014,0.0007255389,0.000004163206,0.0070466814],"genre_scores_gemma":[0.99064815,0.002918608,0.00027408788,0.0043952297,0.00000770001,0.00017975277,0.00016154806,0.000011262906,0.001403678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690396,0.0004701014,0.0011802946,0.00046617028,0.0004997016,0.00047980092],"domain_scores_gemma":[0.9971505,0.0008952428,0.00010264661,0.00090088486,0.00078498106,0.00016573945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005250963,0.00016050905,0.00085375493,0.0012238321,0.000061606006,0.000034509987,0.00044616673,0.0001330098,0.00031742896],"category_scores_gemma":[0.0009940538,0.00011602436,0.0002158417,0.0010697589,0.000497673,0.000078443474,0.0004134563,0.0005960829,0.0000037178834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030769508,0.00080620265,0.9723625,0.00024702988,0.0021192646,0.000009506805,0.00043980064,0.000002631638,0.0000089624455,0.0012471806,0.0045061624,0.015173779],"study_design_scores_gemma":[0.004535652,0.00051869947,0.9863622,0.00010649049,0.00020946811,2.7640746e-7,0.0011265455,0.0018246862,0.0001011994,0.0008454834,0.004280897,0.00008836168],"about_ca_topic_score_codex":0.00021789677,"about_ca_topic_score_gemma":0.00004244816,"teacher_disagreement_score":0.015085418,"about_ca_system_score_codex":0.00018960335,"about_ca_system_score_gemma":0.0003518996,"threshold_uncertainty_score":0.4731336},"labels":[],"label_agreement":null},{"id":"W7116889275","doi":"10.2147/ceor.s567932","title":"Consequences of Canada’s Drug Agency Reimbursement Recommendations for New Medicines and Pan-Canadian Pharmaceutical Alliance Price Negotiations on Patient Access","year":2025,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Arthur B. McDonald-Canadian Astroparticle Physics Research Institute; Fraser Institute; Wilfrid Laurier University; Canadian Institute for Health Information","funders":"","keywords":"Reimbursement; Listing (finance); Government (linguistics); Negotiation; Agency (philosophy); Access to medicines; Alliance","score_opus":0.5671951713696002,"score_gpt":0.5952915884355787,"score_spread":0.02809641706597854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116889275","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25984702,0.0032272509,0.0002683869,0.7233331,0.0016711606,0.0022233815,0.00086904276,0.000012660216,0.008547946],"genre_scores_gemma":[0.9316339,0.0060270424,0.0021986726,0.05334089,0.00024285325,0.0003438399,0.00008378542,0.00003459566,0.006094408],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958335,0.00022670176,0.0027238145,0.0005895174,0.00008709375,0.000539341],"domain_scores_gemma":[0.99255687,0.0057816403,0.00070240785,0.0003824577,0.0001608034,0.00041583285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0083381925,0.00016935998,0.0007764805,0.00045984783,0.00048624462,0.00012764808,0.00035951642,0.0000985515,0.0002338479],"category_scores_gemma":[0.0049639475,0.00019265199,0.00007111623,0.00017430975,0.00023397226,0.00023318063,0.00011149742,0.00026789884,0.00001698776],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043298827,0.000087997105,0.19034266,0.00038665565,0.00021608248,6.609506e-7,0.0011993716,0.000068878435,0.0000012925382,0.32248446,0.4746428,0.010525832],"study_design_scores_gemma":[0.0016343101,0.0001345032,0.11768771,0.00018162487,0.000016772103,8.16201e-7,0.0018986689,0.0022694175,0.00004254844,0.0675346,0.80828667,0.00031238957],"about_ca_topic_score_codex":0.39246732,"about_ca_topic_score_gemma":0.58865297,"teacher_disagreement_score":0.6717869,"about_ca_system_score_codex":0.0007454771,"about_ca_system_score_gemma":0.0037117538,"threshold_uncertainty_score":0.785612},"labels":[],"label_agreement":null}]}